Current developments and prospects of the antibiotic delivery systems

References

• Abdelghany A, El-Desouky MA, Shemis M. 2021. Synthesis and characterization of amoxicillin-loaded polymeric nanocapsules as a drug delivery system targeting Helicobacter pylori. Arab J Gastroenterol. 22(4):278–284. doi: 10.1016/j.ajg.2021.06.002.
   PubMed Web of Science ®Google Scholar
• Abdelghany SM, Quinn DJ, Ingram RJ, Gilmore BF, Donnelly RF, Taggart CC, Scott CJ. 2012. Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomed. 7:4053–4063. doi: 10.2147/IJN.S34341.
   PubMed Web of Science ®Google Scholar
• Abdellatif AAH, Alhumaydhi FA, Rugaie O, Tolba NS, Mousa AM. 2023. Topical silver nanoparticles reduced with ethylcellulose enhance skin wound healing. Eur Rev Med Pharmacol Sci. 27(2):744–754.
   PubMed Web of Science ®Google Scholar
• Abe K, Nomura N, Suzuki S. 2021. Biofilms: hot spots of horizontal gene transfer (HGT) in aquatic environments, with a focus on a new HGT mechanism. FEMS Microbiol Ecol. 96(5):1–12.
   Web of Science ®Google Scholar
• Adnan M, Ali Shah MR, Jamal M, Jalil F, Andleeb S, Nawaz MA, Pervez S, Hussain T, Shah I, Imran M, et al. 2020. Isolation and characterization of bacteriophage to control multidrug-resistant Pseudomonas aeruginosa planktonic cells and biofilm. Biologicals. 63:89–96. doi: 10.1016/j.biologicals.2019.10.003.
   PubMed Web of Science ®Google Scholar
• Agrawal P, Bhalla S, Usmani SS, Singh S, Chaudhary K, Raghava GPS, Gautam A. 2016. CPPsite 2.0: a repository of experimentally validated cell-penetrating peptides. Nucleic Acids Res. 44(D1):D1098–D1103. doi: 10.1093/nar/gkv1266.
   PubMed Web of Science ®Google Scholar
• Ahmad F, Salem-Bekhit MM, Khan F, Alshehri S, Khan A, Ghoneim MM, Wu HF, Taha EI, Elbagory I. 2022. Unique properties of surface-functionalized nanoparticles for bio-application: functionalization mechanisms and importance in application. Nanomater (Basel, Switzerland). 12(8):1333. doi: 10.3390/nano12081333.
   PubMedGoogle Scholar
• Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K. 2013. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8(1):102. doi: 10.1186/1556-276X-8-102.
   PubMed Web of Science ®Google Scholar
• Aliabadi HM, Lavasanifar A. 2006. Polymeric micelles for drug delivery. Expert Opin Drug Deliv. 3(1):139–162. doi: 10.1517/17425247.3.1.139.
   PubMedGoogle Scholar
• Al-Shayeb B, Sachdeva R, Chen LX, Ward F, Munk P, Devoto A, Castelle CJ, Olm MR, Bouma-Gregson K, Amano Y, et al. 2020. Clades of huge phages from across Earth’s ecosystems. Nature. 578(7795):425–431. doi: 10.1038/s41586-020-2007-4.
   PubMed Web of Science ®Google Scholar
• Aminov RI. 2010. A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol. 1:134. doi: 10.3389/fmicb.2010.00134.
   PubMed Web of Science ®Google Scholar
• Andrei S, Droc G, Stefan G. 2019. FDA approved antibacterial drugs: 2018-2019. Discoveries (Craiova). 7(4):e102. doi: 10.15190/d.2019.15.
   PubMedGoogle Scholar
• Antonoplis A, Zang X, Huttner MA, Chong KKL, Lee YB, Co JY, Amieva MR, Kline KA, Wender PA, Cegelski L. 2018. A dual-function antibiotic-transporter conjugate exhibits ­superior activity in sterilizing MRSA biofilms and killing persister cells. J Am Chem Soc. 140(47):16140–16151. doi: 10.1021/jacs.8b08711.
   PubMed Web of Science ®Google Scholar
• Arisawa M, Sekine Y, Shimizu S, Takano H, Angehrn P, Then RL. 1991. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity. Antimicrob Agents Chemother. 35(4):653–659. doi: 10.1128/AAC.35.4.653.
   PubMed Web of Science ®Google Scholar
• Arnusch CJ, Pieters RJ, Breukink E. 2012. Enhanced membrane pore formation through high-affinity targeted antimicrobial peptides. PLoS One. 7(6):e39768. doi: 10.1371/journal.pone.0039768.
   PubMed Web of Science ®Google Scholar
• Assoni L, Milani B, Carvalho MR, Nepomuceno LN, Waz NT, Guerra MES, Converso TR, Darrieux M. 2020. Resistance mechanisms to antimicrobial peptides in gram-positive bacteria. Front Microbiol. 11:593215. doi: 10.3389/fmicb.2020.593215.
   PubMedGoogle Scholar
• Astete CE, Sabliov CM. 2006. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed. 17(3):247–289. doi: 10.1163/156856206775997322.
   PubMed Web of Science ®Google Scholar
• Audrain B, Ferrières L, Zairi A, Soubigou G, Dobson C, Coppée JY, Beloin C, Ghigo JM. 2013. Induction of the Cpx envelope stress pathway contributes to Escherichia coli tolerance to antimicrobial peptides. Appl Environ Microbiol. 79(24):7770–7779. doi: 10.1128/AEM.02593-13.
   PubMed Web of Science ®Google Scholar
• Azarnezhad A, Samadian H, Jaymand M, Sobhani M, Ahmadi A. 2020. Toxicological profile of lipid-based nanostructures: are they considered as completely safe nanocarriers? Crit Rev Toxicol. 50(2):148–176. doi: 10.1080/10408444.2020.1719974.
   PubMed Web of Science ®Google Scholar
• Baig N, Kammakakam I, Falath W, Kammakakam I. 2021. Nanomaterials: a review of synthesis methods, properties, recent progress, and challenges. Mater Adv. 2(6):1821–1871. doi: 10.1039/D0MA00807A.
   Google Scholar
• Balmayor ER, Baran ET, Azevedo HS, Reis RL. 2012. Injectable biodegradable starch/chitosan delivery system for the sustained release of gentamicin to treat bone infections. Carbohydr Polym. 87(1):32–39. doi: 10.1016/j.carbpol.2011.06.078.
   PubMed Web of Science ®Google Scholar
• Bamrungsap S, Zhao Z, Chen T, Wang L, Li C, Fu T, Tan W. 2012. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine (Lond). 7(8):1253–1271. doi: 10.2217/nnm.12.87.
   PubMed Web of Science ®Google Scholar
• Banin E, Vasil ML, Greenberg EP. 2005. Iron and Pseudomonas aeruginosa biofilm formation. Proc Natl Acad Sci U S A. 102(31):11076–11081. doi: 10.1073/pnas.0504266102.
   PubMed Web of Science ®Google Scholar
• Baptista PV, McCusker MP, Carvalho A, Ferreira DA, Mohan NM, Martins M, Fernandes AR. 2018. Nano-strategies to fight multidrug resistant bacteria- “A battle of the titans”. Front Microbiol. 9:1441. doi: 10.3389/fmicb.2018.01441.
   PubMed Web of Science ®Google Scholar
• Bera S, Zhanel GG, Schweizer F. 2011. Synthesis and antibacterial activity of amphiphilic lysine-ligated neomycin B conjugates. Carbohydr Res. 346(5):560–568. doi: 10.1016/j.carres.2011.01.015.
   PubMed Web of Science ®Google Scholar
• Bhandari M, Soria-Carrera H, Wohlmann J, Dal N-JK, de la Fuente JM, Martín-Rapún R, Griffiths G, Fenaroli F. 2023. Subcellular localization and therapeutic efficacy of polymeric micellar nanoparticles encapsulating bedaquiline for tuberculosis treatment in zebrafish. Biomater Sci. 11(6):2103–2114. doi: 10.1039/d2bm01835g.
   PubMed Web of Science ®Google Scholar
• Bhatia E, Banerjee R. 2020. Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection. J Mater Chem B. 8(22):4890–4898. doi: 10.1039/d0tb00158a.
   PubMed Web of Science ®Google Scholar
• Bhatti R, Shakeel H, Malik K, Qasim M, Khan MA, Ahmed N, Jabeen S. 2022. Inorganic nanoparticles: toxic effects, mechanisms of cytotoxicity and phytochemical interactions. Adv Pharm Bull. 12(4):757–762.
   PubMed Web of Science ®Google Scholar
• Bierne H, Milohanic E, Kortebi M. 2018. To be cytosolic or vacuolar: the double life of Listeria monocytogenes. Front Cell Infect Microbiol. 8:136. doi: 10.3389/fcimb.2018.00136.
   PubMed Web of Science ®Google Scholar
• Birk SE, Boisen A, Nielsen LH. 2021. Polymeric nano- and microparticulate drug delivery systems for treatment of biofilms. Adv Drug Deliv Rev. 174:30–52. doi: 10.1016/j.addr.2021.04.005.
   PubMed Web of Science ®Google Scholar
• Blair J. 2017. Making magic bullets. Nat Microbiol. 2(8):17110. doi: 10.1038/nmicrobiol.2017.110.
   PubMedGoogle Scholar
• Blanco-Picazo P, Morales-Cortes S, Ramos-Barbero MD, García-Aljaro C, Rodríguez-Rubio L, Muniesa M. 2023. Dominance of phage particles carrying antibiotic resistance genes in the viromes of retail food sources. Isme J. 17(2):195–203. doi: 10.1038/s41396-022-01338-0.
   PubMed Web of Science ®Google Scholar
• Blencowe CA, Russell AT, Greco F, Hayes W, Thornthwaite DW. 2011. Self-immolative linkers in polymeric delivery systems. Polym Chem. 2(4):773–790. doi: 10.1039/C0PY00324G.
   Web of Science ®Google Scholar
• Boluarte T, Schulze U. 2022. The case for a subscriptiom model to tackle antimicrobical resistance. BCG. https://www.bcg.com/publications/2022/model-for-tackling-antimicrobial-resistancd
   Google Scholar
• Boman HG. 2003. Antibacterial peptides : basic facts and emerging concepts. J Intern Med. 254(3):197–215. doi: 10.1046/j.1365-2796.2003.01228.x.
   PubMed Web of Science ®Google Scholar
• Bowler P, Murphy C, Wolcott R. 2020. Biofilm exacerbates antibiotic resistance: is this a current oversight in antimicrobial stewardship? Antimicrob Resist Infect Control. 9(1):162. doi: 10.1186/s13756-020-00830-6.
   PubMed Web of Science ®Google Scholar
• Braun V, Pramanik A, Gwinner T, Köberle M, Bohn E. 2009. Sideromycins: tools and antibiotics. Biometals. 22(1):3–13. doi: 10.1007/s10534-008-9199-7.
   PubMed Web of Science ®Google Scholar
• Brezden A, Mohamed MF, Nepal M, Harwood JS, Kuriakose J, Seleem MN, Chmielewski J. 2016. Dual targeting of intracellular pathogenic bacteria with a cleavable conjugate of kanamycin and an antibacterial cell-penetrating peptide. J Am Chem Soc. 138(34):10945–10949. doi: 10.1021/jacs.6b04831.
   PubMed Web of Science ®Google Scholar
• Brown AN, Smith K, Samuels TA, Lu J, Obare SO, Scott ME. 2012. Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Appl Environ Microbiol. 78(8):2768–2774. doi: 10.1128/AEM.06513-11.
   PubMed Web of Science ®Google Scholar
• Burnhan BF. 1963. Investigations on the action of the iron-containing growth factors. J Gen Microbiol. 32:117–121. doi: 10.1099/00221287-32-1-117.
   PubMedGoogle Scholar
• Butler MS, Gigante V, Sati H, Paulin S, Al-Sulaiman L, Rex JH, Fernandes P, Arias CA, Paul M, Thwaites GE, et al. 2022. Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, More action is needed. Antimicrob Agents Chemother. 66(3):e0199121. doi: 10.1128/AAC.01991-21.
   PubMed Web of Science ®Google Scholar
• Cal PMSD, Matos MJ, Bernardes GJL. 2017. Trends in therapeutic drug conjugates for bacterial diseases: a patent review. Expert Opin Ther Pat. 27(2):179–189. doi: 10.1080/13543776.2017.1259411.
   PubMed Web of Science ®Google Scholar
• Cavaco M, Castanho MARB, Neves V. 2017. Peptibodies: an elegant solution for a long-standing problem. Biopolymers. 110(1):e23095. doi: 10.1002/bip.23095.
   Google Scholar
• Cavaco M, Castanho MARB, Neves V. 2022. The use of antibody-antibiotic conjugates to fight bacterial infections. Front Microbiol. 13:835677. doi: 10.3389/fmicb.2022.835677.
   PubMed Web of Science ®Google Scholar
• CDC. 2019. Antibiotic resistance threats in the United States. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019.
   Google Scholar
• Chairatana P, Zheng T, Nolan EM. 2015. Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Escherichia coli. Chem Sci. 6(8):4458–4471. doi: 10.1039/c5sc00962f.
   PubMed Web of Science ®Google Scholar
• Changerath R, Nair PD, Mathew S, Nair CPR. 2009. Poly(methyl methacrylate)-grafted chitosan microspheres for controlled release of ampicillin. J Biomed Mater Res B Appl Biomater. 89(1):65–76. doi: 10.1002/jbm.b.31188.
   PubMedGoogle Scholar
• Chanphai P, Konka V, Tajmir-Riahi HA. 2017. Folic acid–chitosan conjugation: a new drug delivery tool. J Mol Liq. 238:155–159. doi: 10.1016/j.molliq.2017.04.132.
   Web of Science ®Google Scholar
• Chau CH, Steeg PS, Figg WD. 2019. Antibody–drug conjugates for cancer. Lancet. 394(10200):793–804. doi: 10.1016/S0140-6736(19)31774-X.
   PubMed Web of Science ®Google Scholar
• Chen X, Guo R, Wang C, Li K, Jiang X, He H, Hong W. 2021. On-demand pH-sensitive surface charge-switchable polymeric micelles for targeting Pseudomonas aeruginosa biofilms development. J Nanobiotechnology. 19(1):99. doi: 10.1186/s12951-021-00845-0.
   PubMed Web of Science ®Google Scholar
• Chen H, Liu C, Chen D, Madrid K, Peng S, Dong X, Zhang M, Gu Y. 2015. Bacteria-targeting conjugates based on antimicrobial peptide for bacteria diagnosis and therapy. Mol Pharm. 12(7):2505–2516. doi: 10.1021/acs.molpharmaceut.5b00053.
   PubMedGoogle Scholar
• Chlumsky O, Purkrtova S, Michova H, Svarcova V, Slepicka P, Fajstavr D, Ulbrich P, Demnerova K. 2020. The effect of gold and silver nanoparticles, chitosan and their combinations on bacterial biofilms of food-borne pathogens. Biofouling. 36(2):222–233. doi: 10.1080/08927014.2020.1751132.
   PubMed Web of Science ®Google Scholar
• Chu BC, Garcia-Herrero A, Johanson TH, Krewulak KD, Lau CK, Peacock RS, Slavinskaya Z, Vogel HJ. 2010. Siderophore uptake in bacteria and the battle for iron with the host; a bird’s eye view. Biometals. 23(4):601–611. doi: 10.1007/s10534-010-9361-x.
   PubMed Web of Science ®Google Scholar
• Cipolla D, Blanchard J, Gonda I. 2016. Development of liposomal ciprofloxacin to treat lung infections. Pharmaceutics. 8(1):6. doi: 10.3390/pharmaceutics8010006.
   PubMed Web of Science ®Google Scholar
• Clancy JP, Dupont L, Konstan MW, Billings J, Fustik S, Goss CH, Lymp J, Minic P, Quittner AL, Rubenstein RC, et al. 2013. Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection. Thorax. 68(9):818–825. doi: 10.1136/thoraxjnl-2012-202230.
   PubMed Web of Science ®Google Scholar
• Coates AR, Halls G, Hu Y. 2011. Novel classes of antibiotics or more of the same? Br J Pharmacol. 163(1):184–194. doi: 10.1111/j.1476-5381.2011.01250.x.
   PubMed Web of Science ®Google Scholar
• Cypriyana P J J, S S, Angalene J LA, Samrot AV, Kumar S S, Ponniah P, Chakravarthi S. 2021. Overview on toxicity of nanoparticles, it’s mechanism, models used in toxicity studies and disposal methods – a review. Biocatal Agric Biotechnol. 36:102117. doi: 10.1016/j.bcab.2021.102117.
   Web of Science ®Google Scholar
• Dassonville-Klimpt A, Sonnet P. 2020. Advances in “Trojan horse” strategies in antibiotic delivery systems. Future Med Chem. 12(11):983–986. doi: 10.4155/fmc-2020-0065.
   PubMed Web of Science ®Google Scholar
• De Matteis V. 2017. Exposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in vitro/In vivo toxicity evaluation. Toxics. 5(4):29. doi: 10.3390/toxics5040029.
   PubMed Web of Science ®Google Scholar
• de Oliveira Júnior NG, Franco OL. 2020. Promising strategies for future treatment of Klebsiella pneumoniae biofilms. Future Microbiol. 15(1):63–79. doi: 10.2217/fmb-2019-0180.
   PubMed Web of Science ®Google Scholar
• De Soir S, Parée H, Kamarudin NHN, Wagemans J, Lavigne R, Braem A, Merabishvili M, De Vos D, Pirnay J-P, Van Bambeke F. 2024. Exploiting phage-antibiotic synergies to disrupt Pseudomonas aeruginosa PAO1 biofilms in the context of orthopedic infections. Microbiol Spectr. 12(1):e0321923. doi: 10.1128/spectrum.03219-23.
   PubMed Web of Science ®Google Scholar
• Defaus S, Gallo M, Abengózar MA, Rivas L, Andreu D. 2017. A synthetic strategy for conjugation of paromomycin to cell-penetrating tat(48-60) for delivery and visualization into leishmania parasites. Int J Pept. 2017:4213037–4213037. doi: 10.1155/2017/4213037.
   PubMedGoogle Scholar
• Deng R, Zhou C, Li D, Cai H, Sukumaran S, Carrasco-Triguero M, Saad O, Nazzal D, Lowe C, Ramanujan S, et al. 2019. Preclinical and translational pharmacokinetics of a novel THIOMABTM antibody-antibiotic conjugate against Staphylococcus aureus. MAbs. 11(6):1162–1174. doi: 10.1080/19420862.2019.1627152.
   PubMed Web of Science ®Google Scholar
• Deore AB, Dhumane JR, Wagh R, Sonawane R. 2019. The stages of drug discovery and development process. Asian J Pharm Res Dev. 7(6):62–67. doi: 10.22270/ajprd.v7i6.616.
   Google Scholar
• Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A. 1996. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem. 271(30):18188–18193. doi: 10.1074/jbc.271.30.18188.
   PubMed Web of Science ®Google Scholar
• Deshayes C, Arafath MN, Apaire-Marchais V, Roger E. 2021. Drug delivery systems for the oral administration of antimicrobial peptides: promising tools to treat infectious diseases. Front Med Technol. 3:778645. doi: 10.3389/fmedt.2021.778645.
   PubMedGoogle Scholar
• Deshayes S, Morris MC, Divita G, Heitz F. 2006. Interactions of amphipathic CPPs with model membranes. Biochim Biophys Acta - Biomembr. 1758(3):328–335. doi: 10.1016/j.bbamem.2005.10.004.
   PubMed Web of Science ®Google Scholar
• Deshayes S, Xian W, Schmidt NW, Kordbacheh S, Lieng J, Wang J, Zarmer S, Germain SS, Voyen L, Thulin J, et al. 2017. Designing hybrid antibiotic peptide conjugates to cross bacterial membranes. Bioconjug Chem. 28(3):793–804.,. doi: 10.1021/acs.bioconjchem.6b00725.
   PubMed Web of Science ®Google Scholar
• Deusenbery C, Gomez Casas C, Shukla A. 2023. pH-Responsive swelling micelles for the treatment of methicillin-resistant Staphylococcus aureus biofilms. ACS Appl Polym Mater. 5(9):7400–7410. doi: 10.1021/acsapm.3c01307.
   Google Scholar
• Ding D, Zhu Q. 2018. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics. Mater Sci Eng C Mater Biol Appl. 92:1041–1060. doi: 10.1016/j.msec.2017.12.036.
   PubMed Web of Science ®Google Scholar
• Domingo-Calap P, Delgado-Martínez J. 2018. Bacteriophages: protagonists of a post-antibiotic era. Antibiotics. 7(3):66. doi: 10.3390/antibiotics7030066.
   Google Scholar
• Doore SM, Schrad JR, Dean WF, Dover JA, Parent KN. 2018. Shigella phages isolated during a dysentery outbreak reveal uncommon structures and broad species diversity. J Virol. 92(8):e02117–17. doi: 10.1128/JVI.02117-17.
   PubMed Web of Science ®Google Scholar
• Dorati R, De Trizio A, Genta I, Merelli A, Modena T, Conti B. 2016. Formulation and in vitro characterization of a ­composite biodegradable scaffold as antibiotic delivery system and regenerative device for bone. J Drug Deliv Sci Technol. 35:124–133. doi: 10.1016/j.jddst.2016.04.008.
   Web of Science ®Google Scholar
• dos Santos VE, JrVasconcelos Filho A, Targino AGR, Flores MAP, Galembeck A, CaldasJrAF, Rosenblatt A. 2014. A new “silver-bullet” to treat caries in children–nano silver fluoride: a randomised clinical trial. J Dent. 42(8):945–951. doi: 10.1016/j.jdent.2014.05.017.
   PubMed Web of Science ®Google Scholar
• Ekins S. 2014. Hacking into the granuloma: could antibody antibiotic conjugates be developed for TB? Tuberculosis (Edinb). 94(6):715–716. doi: 10.1016/j.tube.2014.08.009.
   PubMed Web of Science ®Google Scholar
• El Shazely B, Yu G, Johnston PR, Rolff J. 2020. Resistance evolution against antimicrobial peptides in Staphylococcus aureus alters pharmacodynamics beyond the MIC. Front Microbiol. 11:103. doi: 10.3389/fmicb.2020.00103.
   PubMed Web of Science ®Google Scholar
• El-Alfy EA, El-Bisi MK, Taha GM, Ibrahim HM. 2020. Preparation of biocompatible chitosan nanoparticles loaded by tetracycline, gentamycin and ciprofloxacin as novel drug delivery system for improvement the antibacterial properties of cellulose based fabrics. Int J Biol Macromol. 161:1247–1260. doi: 10.1016/j.ijbiomac.2020.06.118.
   PubMed Web of Science ®Google Scholar
• El-Andaloussi S, Holm T, Langel U. 2005. Cell-penetrating peptides: mechanisms and applications. Curr Pharm Des. 11(28):3597–3611. doi: 10.2174/138161205774580796.
   PubMed Web of Science ®Google Scholar
• Elliott G, O’Hare P. 1997. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 88(2):223–233. doi: 10.1016/s0092-8674(00)81843-7.
   PubMed Web of Science ®Google Scholar
• Emelianova AA, Kuzmin DV, Panteleev PV, Sorokin M, Buzdin AA, Ovchinnikova TV. 2018. Anticancer activity of the goat antimicrobial peptide ChMAP-28. Front Pharmacol. 9:1501. doi: 10.3389/fphar.2018.01501.
   PubMed Web of Science ®Google Scholar
• Epand RM, Epand RF. 2011. Bacterial membrane lipids in the action of antimicrobial agents. J Pept Sci. 17(5):298–305. doi: 10.1002/psc.1319.
   PubMed Web of Science ®Google Scholar
• Esmaeillou M, Zarrini G, Rezaee MA, Mojarrad JS, Bahadori A. 2017. Vancomycin capped with silver nanoparticles as an antibacterial agent against multi-drug resistance bacteria. Adv Pharm Bull. 7(3):479–483. doi: 10.15171/apb.2017.058.
   PubMed Web of Science ®Google Scholar
• Etayash H, Alford M, Akhoundsadegh N, Drayton M, Straus SK, Hancock REW. 2021. Multifunctional antibiotic–host defense peptide conjugate kills bacteria, eradicates biofilms, and modulates the innate immune response. J Med Chem. 64(22):16854–16863. doi: 10.1021/acs.jmedchem.1c01712.
   PubMed Web of Science ®Google Scholar
• Etayash H, Pletzer D, Kumar P, Straus SK, Hancock REW. 2020. Cyclic derivative of host-defense peptide IDR-1018 improves proteolytic stability, suppresses inflammation, and enhances in vivo activity. J Med Chem. 63(17):9228–9236. doi: 10.1021/acs.jmedchem.0c00303.
   PubMed Web of Science ®Google Scholar
• Fadaka AO, Sibuyi NRS, Madiehe AM, Meyer M. 2021. Nanotechnology-based delivery systems for antimicrobial peptides. Pharmaceutics. 13(11):1795. doi: 10.3390/pharmaceutics13111795.
   PubMed Web of Science ®Google Scholar
• Fardeau S, Dassonville-Klimpt A, Audic N, Sasaki A, Pillon M, Baudrin E, Mullié C, Sonnet P. 2014. Synthesis and antibacterial activity of catecholate-ciprofloxacin conjugates. Bioorg Med Chem. 22(15):4049–4060. doi: 10.1016/j.bmc.2014.05.067.
   PubMed Web of Science ®Google Scholar
• Feyissa Z, Edossa GD, Gupta NK, Negera D. 2023. Development of double crosslinked sodium alginate/chitosan based hydrogels for controlled release of metronidazole and its antibacterial activity. Heliyon. 9(9):e20144. doi: 10.1016/j.heliyon.2023.e20144.
   PubMed Web of Science ®Google Scholar
• Fokine A, Islam MZ, Zhang Z, Bowman VD, Rao VB, Rossmann MG. 2011. Structure of the three N-terminal immunoglobulin domains of the highly immunogenic outer capsid protein from a T4-like bacteriophage. J Virol. 85(16):8141–8148. doi: 10.1128/JVI.00847-11.
   PubMed Web of Science ®Google Scholar
• Frankel AD, Pabo CO. 1988. Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 55(6):1189–1193. doi: 10.1016/0092-8674(88)90263-2.
   PubMed Web of Science ®Google Scholar
• Frimodt-Møller J, Koulouktsis A, Charbon G, Otterlei M, Nielsen PE, Løbner-Olesen A. 2021. Activating the Cpx response induces tolerance to antisense PNA delivered by an arginine-rich peptide in Escherichia coli. Mol Ther Nucleic Acids. 25:444–454. doi: 10.1016/j.omtn.2021.06.009.
   PubMedGoogle Scholar
• Fu Z, Li S, Han S, Shi C, Zhang Y. 2022. Antibody drug conjugate: the “biological missile” for targeted cancer therapy. Signal Transduct Target Ther. 7(1):93.
   PubMed Web of Science ®Google Scholar
• Fuller A, Whiley H, Köper I. 2020. Antibiotic delivery using gold nanoparticles. SN Appl Sci. 2(6):1–7. doi: 10.1007/s42452-020-2835-8.
   Web of Science ®Google Scholar
• Furfaro LL, Payne MS, Chang BJ. 2018. Bacteriophage therapy: clinical trials and regulatory hurdles. Front Cell Infect Microbiol. 8:376. doi: 10.3389/fcimb.2018.00376.
   PubMed Web of Science ®Google Scholar
• García-Cruz JC, Rebollar-Juarez X, Limones-Martinez A, Santos-Lopez CS, Toya S, Maeda T, Ceapă CD, Blasco L, Tomás M, Díaz-Velásquez CE, et al. 2023. Resistance against two lytic phage variants attenuates virulence and antibiotic resistance in Pseudomonas aeruginosa. Front Cell Infect Microbiol. 13:1280265.,. doi: 10.3389/fcimb.2023.1280265.
   PubMed Web of Science ®Google Scholar
• Gasser V, Baco E, Cunrath O, August PS, Perraud Q, Zill N, Schleberger C, Schmidt A, Paulen A, Bumann D, et al. 2016. Catechol siderophores repress the pyochelin pathway and activate the enterobactin pathway in Pseudomonas aeruginosa: an opportunity for siderophore-antibiotic conjugates development. Environ Microbiol. 18(3):819–832.,. doi: 10.1111/1462-2920.13199.
   PubMed Web of Science ®Google Scholar
• Gaurav A, Bakht P, Saini M, Pandey S, Pathania R. 2023. Role of bacterial efflux pumps in antibiotic resistance, virulence, and strategies to discover novel efflux pump inhibitors. Microbiology. 169(5):001333. doi: 10.1099/mic.0.001333.
   PubMed Web of Science ®Google Scholar
• Gause GF, Biol D. 1955. Recent studies on alromycin, a new antibiotic. Br Med J. 2(4949):1177–1179. doi: 10.1136/bmj.2.4949.1177.
   PubMedGoogle Scholar
• Gembara K, Dąbrowska K. 2024. Interaction of bacteriophages with the immune system: induction of bacteriophage-specific antibodies. Methods Mol Biol. 2734:186–196. doi: 10.1007/978-1-0716-3523-0_12.
   Google Scholar
• Ghaffar K, Hussein W, Khalil Z, Capon R, Skwarczynski M, Toth I. 2015. Levofloxacin and indolicidin for combination antimicrobial therapy. Curr Drug Deliv. 12(1):108–114. doi: 10.2174/1567201811666140910094050.
   PubMed Web of Science ®Google Scholar
• Ghai I, Ghai S. 2018. Understanding antibiotic resistance via outer membrane permeability. Infect Drug Resist. 11:523–530. doi: 10.2147/IDR.S156995.
   PubMed Web of Science ®Google Scholar
• Gharibshahian M, Salehi M, Beheshtizadeh N, Kamalabadi-Farahani M, Atashi A, Nourbakhsh MS, Alizadeh M. 2023. Recent advances on 3D-printed PCL-based composite scaffolds for bone tissue engineering. Front Bioeng Biotechnol. 11:1168504. doi: 10.3389/fbioe.2023.1168504.
   PubMed Web of Science ®Google Scholar
• Gholap AD, Rojekar S, Kapare HS, Vishwakarma N, Raikwar S, Garkal A, Mehta TA, Jadhav H, Prajapati MK, Annapure U. 2024. Chitosan scaffolds: expanding horizons in biomedical applications. Carbohydr Polym. 323:121394. doi: 10.1016/j.carbpol.2023.121394.
   PubMed Web of Science ®Google Scholar
• Ghosh M, Miller MJ. 1996. Synthesis and in vitro antibacterial activity of spermidine-based mixed catechol- and hydroxamate-containing siderophore-vancomycin conjugates. Bioorg Med Chem. 4(1):43–48. doi: 10.1016/0968-0896(95)00161-1.
   PubMed Web of Science ®Google Scholar
• Ghosh M, Miller PA, Möllmann U, Claypool WD, Schroeder VA, Wolter WR, Suckow M, Yu H, Li S, Huang W, et al. 2017. Targeted antibiotic delivery: selective siderophore conjugation with daptomycin confers potent activity against multidrug resistant Acinetobacter baumannii both in vitro and in vivo. J Med Chem. 60(11):4577–4583. doi: 10.1021/acs.jmedchem.7b00102.
   PubMed Web of Science ®Google Scholar
• Gomarasca M, Martins TFC, Greune L, Hardwidge PR, Schmidt MA, Rüter C. 2017. Bacterium-derived cell-penetrating peptides deliver gentamicin to kill intracellular pathogens. Antimicrob Agents Chemother. 61(4):e02545-16. doi: 10.1128/AAC.02545-16.
   PubMed Web of Science ®Google Scholar
• Gomez JA, Chen J, Ngo J, Hajkova D, Yeh IJ, Gama V, Miyagi M, Matsuyama S. 2010. Cell-penetrating penta-peptides (CPP5s): measurement of cell entry and protein-transduction activity. Pharmaceuticals (Basel). 3(12):3594–3613. doi: 10.3390/ph3123594.
   PubMedGoogle Scholar
• Gomis-Font MA, Clari MA, López-Causapé C, Navarro D, Oliver A. 2024. Emergence of cefiderocol resistance during ceftazidime/avibactam treatment caused by a large genomic deletion, including ampD and piuCD genes, in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 68(1):e0119223. doi: 10.1128/aac.01192-23.
   PubMed Web of Science ®Google Scholar
• Górska A, Sloderbach A, Marszałł MP. 2014. Siderophore-drug complexes: potential medicinal applications of the “Trojan horse” strategy. Trends Pharmacol Sci. 35(9):442–449. doi: 10.1016/j.tips.2014.06.007.
   PubMed Web of Science ®Google Scholar
• Goulet DR, Atkins WM. 2020. Considerations for the design of antibody-based therapeutics. J Pharm Sci. 109(1):74–103. doi: 10.1016/j.xphs.2019.05.031.
   PubMed Web of Science ®Google Scholar
• Green M, Loewenstein PM. 1988. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell. 55(6):1179–1188. doi: 10.1016/0092-8674(88)90262-0.
   PubMed Web of Science ®Google Scholar
• Grumezescu AM, Andronescu E, Holban AM, Ficai A, Ficai D, Voicu G, Grumezescu V, Balaure PC, Chifiriuc CM. 2013. Water dispersible cross-linked magnetic chitosan beads for increasing the antimicrobial efficiency of aminoglycoside antibiotics. Int J Pharm. 454(1):233–240. doi: 10.1016/j.ijpharm.2013.06.054.
   PubMedGoogle Scholar
• Guarino V, Gentile G, Sorrentino L, Ambrosio L. 2017. Polycaprolactone: synthesis, properties, and applications. Encycl Polym Sci Technol. John Wiley & Sons, Ltd. p.1–36. doi: 10.1002/0471440264.pst658
   Google Scholar
• Guidotti G, Brambilla L, Rossi D. 2017. Cell-penetrating peptides: from basic research to clinics. Trends Pharmacol Sci. 38(4):406–424. doi: 10.1016/j.tips.2017.01.003.
   PubMed Web of Science ®Google Scholar
• Günday Türeli N, Torge A, Juntke J, Schwarz BC, Schneider-Daum N, Türeli AE, Lehr CM, Schneider M. 2017. Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections. Eur J Pharm Biopharm. 117:363–371. doi: 10.1016/j.ejpb.2017.04.032.
   PubMed Web of Science ®Google Scholar
• Guo R, Li K, Tian B, Wang C, Chen X, Jiang X, He H, Hong W. 2021. Elaboration on the architecture of pH-sensitive surface charge-adaptive micelles with enhanced penetration and bactericidal activity in biofilms. J Nanobiotechnology. 19(1):232. doi: 10.1186/s12951-021-00980-8.
   PubMed Web of Science ®Google Scholar
• Halasohoris SA, Scarff JM, Pysz LM, Lembirik S, Lemmon MM, Biek D, Hannah B, Zumbrun SD, Panchal RG. 2021. In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens. J Antibiot (Tokyo). 74(12):884–892. doi: 10.1038/s41429-021-00472-9.
   PubMed Web of Science ®Google Scholar
• Hampton HG, Watson BNJ, Fineran PC. 2020. The arms race between bacteria and their phage foes. Nature. 577(7790):327–336. doi: 10.1038/s41586-019-1894-8.
   PubMed Web of Science ®Google Scholar
• Han P, Zhang W, Pu M, Li Y, Song L, An X, Li M, Li F, Zhang S, Fan H, et al. 2022. Characterization of the bacteriophage BUCT603 and therapeutic potential evaluation against drug-resistant stenotrophomonas maltophilia in a mouse model. Front Microbiol. 13:906961. doi: 10.3389/fmicb.2022.906961.
   PubMed Web of Science ®Google Scholar
• Hassan D, Omolo CA, Fasiku VO, Mocktar C, Govender T. 2020. Novel chitosan-based pH-responsive lipid-polymer hybrid nanovesicles (OLA-LPHVs) for delivery of vancomycin against methicillin-resistant Staphylococcus aureus infections. Int J Biol Macromol. 147:385–398. doi: 10.1016/j.ijbiomac.2020.01.019.
   PubMed Web of Science ®Google Scholar
• Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O’Donnell AE. 2019. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials. Lancet Respir Med. 7(3):213–226. doi: 10.1016/S2213-2600(18)30427-2.
   PubMed Web of Science ®Google Scholar
• Hemmingsen LM, Giordani B, Paulsen MH, Vanić Ž, Flaten GE, Vitali B, Basnet P, Bayer A, Strøm MB, Škalko-Basnet N. 2023. Tailored anti-biofilm activity – liposomal delivery for mimic of small antimicrobial peptide. Biomater Adv. 145:213238. doi: 10.1016/j.bioadv.2022.213238.
   PubMedGoogle Scholar
• Henriques ST, Melo MN, Castanho MARB. 2006. Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem J. 399(1):1–7. doi: 10.1042/BJ20061100.
   PubMedGoogle Scholar
• Hider RC, Kong X. 2010. Chemistry and biology of siderophores. Nat Prod Rep. 27(5):637–657. doi: 10.1039/b906679a.
   PubMed Web of Science ®Google Scholar
• Hirsch JG. 1960. Antimicrobial factors in tissues and phagocytic cells. Bacteriol Rev. 24(1):133–140. doi: 10.1128/br.24.1.133-140.1960.
   PubMedGoogle Scholar
• Horváth M, Kovács T, Koderivalappil S, Ábrahám H, Rákhely G, Schneider G. 2020. Identification of a newly isolated lytic bacteriophage against K24 capsular type, carbapenem resistant Klebsiella pneumoniae isolates. Sci Rep. 10(1):5891. doi: 10.1038/s41598-020-62691-8.
   PubMed Web of Science ®Google Scholar
• Huang Z, Liu H, Zhang X, Tang M, Lin Y, Feng L, Ye J, Zhou T, Chen L. 2023. Ceftazidime-decorated gold nanoparticles: a promising strategy against clinical ceftazidime-avibactam-resistant enterobacteriaceae with different resistance mechanisms. Antimicrob Agents Chemother. 67(7):e0026223. doi: 10.1128/aac.00262-23.
   PubMed Web of Science ®Google Scholar
• Hussein SM, Sofoluwe A, Paleja A, Duhme-Klair A, Thomas MS. 2024. Identification of a system for hydroxamate xenosiderophore-mediated iron transport in Burkholderia cenocepacia. Microbiology (Reading). 170(1):001425. doi: 10.1099/mic.0.001425.
   PubMedGoogle Scholar
• Ibraheem DR, Hussein NN, Sulaiman GM, Mohammed HA, Khan RA, Al Rugaie O. 2022. Ciprofloxacin-loaded silver nanoparticles as potent nano-antibiotics against resistant pathogenic bacteria. Nanomaterials. 12(16):2808. doi: 10.3390/nano12162808.
   Web of Science ®Google Scholar
• Ibrahim HR, Tatsumoto S, Hajime O, Van Immerseel F, Raspoet R, Miyata T. 2015. A novel antibiotic-delivery system by using ovotransferrin as targeting molecule. Eur J Pharm Sci. 66:59–69. doi: 10.1016/j.ejps.2014.10.005.
   PubMed Web of Science ®Google Scholar
• Imamovic L, Sommer MOA. 2013. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med. 5(204):204ra132. doi: 10.1126/scitranslmed.3006609.
   PubMed Web of Science ®Google Scholar
• Inomata T, Endo S, Ido H, Mori R, Iwai Y, Ozawa T, Masuda H. 2023. Iron(III) complexes with hybrid-type artificial siderophores containing catecholate and hydroxamate sites. Inorg Chem. 62(40):16362–16377. doi: 10.1021/acs.inorgchem.3c01786.
   PubMed Web of Science ®Google Scholar
• Inoue G, Toyohara D, Mori T, Muraoka T. 2021. Critical side chain effects of cell-penetrating peptides for transporting oligo peptide nucleic acids in bacteria. ACS Appl Bio Mater. 4(4):3462–3468. doi: 10.1021/acsabm.1c00023.
   PubMedGoogle Scholar
• Jabbari P, Mahdavinia GR, Rezaei PF, Heragh BK, Labib P, Jafari H, Javanshir S. 2023. pH-responsive magnetic biocompatible chitosan-based nanocomposite carrier for ciprofloxacin release. Int J Biol Macromol. 250:126228. doi: 10.1016/j.ijbiomac.2023.126228.
   PubMed Web of Science ®Google Scholar
• Jafari S, Maleki Dizaj S, Adibkia K. 2015. Cell-penetrating peptides and their analogues as novel nanocarriers for drug delivery. Bioimpacts. 5(2):103–111. doi: 10.15171/bi.2015.10.
   PubMedGoogle Scholar
• Jamil KM, Haque R, Rahman R, Faiz MA, Bhuiyan ATMRH, Kumar A, Hassan SM, Kelly H, Dhalaria P, Kochhar S, et al. 2015. Effectiveness study of paromomycin IM injection (PMIM) for the treatment of visceral Leishmaniasis (VL) in Bangladesh. PLoS Negl Trop Dis. 9(10):e0004118.,. doi: 10.1371/journal.pntd.0004118.
   PubMed Web of Science ®Google Scholar
• Jansen M, Wahida A, Latz S, Krüttgen A, Häfner H, Buhl EM, Ritter K, Horz HP. 2018. Enhanced antibacterial effect of the novel T4-like bacteriophage KARL-1 in combination with antibiotics against multi-drug resistant Acinetobacter baumannii. Sci Rep. 8(1):14140. doi: 10.1038/s41598-018-32344-y.
   PubMed Web of Science ®Google Scholar
• Järver P, Mäger I, Langel Ü. 2010. In vivo biodistribution and efficacy of peptide mediated delivery. Trends Pharmacol Sci. 31(11):528–535. doi: 10.1016/j.tips.2010.07.006.
   PubMed Web of Science ®Google Scholar
• Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK. 2018. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol. 9:1050–1074. doi: 10.3762/bjnano.9.98.
   PubMed Web of Science ®Google Scholar
• Jia Y, Joly H, Omri A. 2010. Characterization of the interaction between liposomal formulations and Pseudomonas aeruginosa. J Liposome Res. 20(2):134–146. doi: 10.3109/08982100903218892.
   PubMed Web of Science ®Google Scholar
• Jorge P, Grzywacz D, Kamysz W, Lourenço A, Pereira MO. 2017. Searching for new strategies against biofilm infections: colistin-AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single-and double-species biofilms. PLoS One. 12(3):e0174654. doi: 10.1371/journal.pone.0174654.
   PubMed Web of Science ®Google Scholar
• Joseph M, Trinh HM, Mitra AK. 2017. Chapter 7 - Peptide and protein-based therapeutic agents. In Mitra AK, Cholkar K, Mandal A, editors. Emerg nanotechnologies diagnostics, drug deliv med devices. Elsevier; 145–167.
   Google Scholar
• Kajihara KK, Pantua H, Hernandez-Barry H, Hazen M, Deshmukh K, Chiang N, Ohri R, Castellanos ER, Martin L, Matsumoto ML, et al. 2021. Potent killing of Pseudomonas aeruginosa by an antibody-antibiotic conjugate. MBio. 12(3):e0020221.,. doi: 10.1128/mBio.00202-21.
   PubMed Web of Science ®Google Scholar
• Kalinowski DS, Richardson DR. 2005. The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev. 57(4):547–583. doi: 10.1124/pr.57.4.2.
   PubMed Web of Science ®Google Scholar
• Kamat S, Kumari M. 2023. Emergence of microbial resistance against nanoparticles: mechanisms and strategies. Front Microbiol. 14:1102615. doi: 10.3389/fmicb.2023.1102615.
   PubMed Web of Science ®Google Scholar
• Karakonstantis S, Rousaki M, Vassilopoulou L, Kritsotakis EI. 2024. Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis. Clin Microbiol Infect. 30(2):178–188. doi: 10.1016/j.cmi.2023.08.029.
   PubMed Web of Science ®Google Scholar
• Kardani K, Milani A,H, Shabani S, Bolhassani A. 2019. Cell penetrating peptides: the potent multi-cargo intracellular carriers. Expert Opin Drug Deliv. 16(11):1227–1258. doi: 10.1080/17425247.2019.1676720.
   PubMed Web of Science ®Google Scholar
• Karnwal A, Kumar G, Pant G, Hossain K, Ahmad A, Alshammari MB. 2023. Perspectives on usage of functional nanomaterials in antimicrobial therapy for antibiotic-resistant bacterial infections. ACS Omega. 8(15):13492–13508. doi: 10.1021/acsomega.3c00110.
   PubMed Web of Science ®Google Scholar
• Kauffman KM, Chang WK, Brown JM, Hussain FA, Yang J, Polz MF, Kelly L. 2022. Resolving the structure of phage–bacteria interactions in the context of natural diversity. Nat Commun. 13(1):372. doi: 10.1038/s41467-021-27583-z.
   PubMed Web of Science ®Google Scholar
• Khan I, Saeed K, Khan I. 2019. Nanoparticles: properties, applications and toxicities. Arab J Chem. 12(7):908–931. doi: 10.1016/j.arabjc.2017.05.011.
   Web of Science ®Google Scholar
• Kim A, Kutschke A, Ehmann DE, Patey SA, Crandon JL, Gorseth E, Miller AA, McLaughlin RE, Blinn CM, Chen A, et al. 2015. Pharmacodynamic profiling of a siderophore-conjugated monocarbam in Pseudomonas aeruginosa: assessing the risk for resistance and attenuated efficacy. Antimicrob Agents Chemother. 59(12):7743–7752. doi: 10.1128/AAC.00831-15.
   PubMed Web of Science ®Google Scholar
• Kim DY, Yeom S, Park J, Lee H, Kim HJ. 2023. Cytoplasmic delivery of an antibiotic, trimethoprim, with a simple bidentate catechol analog as a siderophore mimetic. ACS Infect Dis. 9(3):554–566. doi: 10.1021/acsinfecdis.2c00556.
   PubMedGoogle Scholar
• Kircheva N, Dudev T. 2020. Gallium as an antibacterial agent: a DFT/SMD Study of the Ga3+/Fe3+ competition for binding bacterial siderophores. Inorg Chem. 59(9):6242–6254. doi: 10.1021/acs.inorgchem.0c00367.
   PubMed Web of Science ®Google Scholar
• Klebba PE. 2016. ROSET model of TonB action in gram-negative bacterial iron acquisition. J Bacteriol. 198(7):1013–1021. doi: 10.1128/JB.00823-15.
   PubMed Web of Science ®Google Scholar
• Köhler G, Milstein C. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256(5517):495–497. doi: 10.1038/256495a0.
   PubMed Web of Science ®Google Scholar
• Kong H, Cheng W, Wei H, Yuan Y, Yang Z, Zhang X. 2019. An overview of recent progress in siderophore-antibiotic conjugates. Eur J Med Chem. 182:111615. doi: 10.1016/j.ejmech.2019.111615.
   PubMed Web of Science ®Google Scholar
• Koren E, Torchilin VP. 2012. Cell-penetrating peptides: breaking through to the other side. Trends Mol Med. 18(7):385–393. doi: 10.1016/j.molmed.2012.04.012.
   PubMed Web of Science ®Google Scholar
• Kostova V, Désos P, Starck JB, Kotschy A. 2021. The chemistry behind adcs. Pharmaceuticals. 14(5):442. doi: 10.3390/ph14050442.
   Web of Science ®Google Scholar
• Kou S, Peters LM, Mucalo MR. 2021. Chitosan: a review of sources and preparation methods. Int J Biol Macromol. 169:85–94. doi: 10.1016/j.ijbiomac.2020.12.005.
   PubMed Web of Science ®Google Scholar
• Kuaté Tokam CR, Bisso Ndezo B, Boulens N, Allémann E, Delie F, Dzoyem JP. 2023. Antibiofilm activity and synergistic ­effects of thymol-loaded poly (lactic-co-glycolic acid) nanoparticles with amikacin against four Salmonella enterica serovars. Can J Infect Dis Med Microbiol. 2023:7274309–7274313. doi: 10.1155/2023/7274309.
   PubMed Web of Science ®Google Scholar
• Kumar L, Bisen M, Harjai K, Chhibber S, Azizov S, Lalhlenmawia H, Kumar D. 2023. Advances in nanotechnology for biofilm inhibition. ACS Omega. 8(24):21391–21409. doi: 10.1021/acsomega.3c02239.
   PubMed Web of Science ®Google Scholar
• Kumar M, Pandey SK, Lalhall A, Sharma R, Sharma RK, Wangoo N. 2023. Targeting bacterial biofilms using vancomycin and multivalent cell-penetrating peptide labeled quantum dots. J Biomed Mater Res B Appl Biomater. 111(2):284–294. doi: 10.1002/jbm.b.35150.
   PubMed Web of Science ®Google Scholar
• Kyriakides TR, Raj A, Tseng TH, Xiao H, Nguyen R, Mohammed FS, Halder S, Xu M, Wu MJ, Bao S, et al. 2021. Biocompatibility of nanomaterials and their immunological properties. Biomed Mater. 16(4):042005. doi: 10.1088/1748-605X/abe5fa.
   Web of Science ®Google Scholar
• Lambert PA. 2005. Bacterial resistance to antibiotics: modified target sites. Adv Drug Deliv Rev. 57(10):1471–1485. doi: 10.1016/j.addr.2005.04.003.
   PubMed Web of Science ®Google Scholar
• Lee H-M, Ren J, Tran KM, Jeon B-M, Park W-U, Kim H, Lee KE, Oh Y, Choi M, Kim D-S, et al. 2021. Identification of efficient prokaryotic cell-penetrating peptides with applications in bacterial biotechnology. Commun Biol. 4(1):205. doi: 10.1038/s42003-021-01726-w.
   PubMed Web of Science ®Google Scholar
• Lee YR, Yeo S. 2020. Cefiderocol, a new siderophore cephalosporin for the treatment of complicated urinary tract infections caused by multidrug-resistant pathogens: preclinical and clinical pharmacokinetics, pharmacodynamics, efficacy and safety. Clin Drug Investig. 40(10):901–913. doi: 10.1007/s40261-020-00955-x.
   PubMed Web of Science ®Google Scholar
• Lehar SM, Pillow T, Xu M, Staben L, Kajihara KK, Vandlen R, DePalatis L, Raab H, Hazenbos WL, Hiroshi Morisaki J, et al. 2015. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Nature. 527(7578):323–328. doi: 10.1038/nature16057.
   PubMed Web of Science ®Google Scholar
• Leszczynska K, Namiot D, Byfield FJ, Cruz K, Zendzian-Piotrowska M, Fein DE, Savage PB, Diamond S, McCulloch CA, Janmey PA, et al. 2013. Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections. J Antimicrob Chemother. 68(3):610–618. doi: 10.1093/jac/dks434.
   PubMed Web of Science ®Google Scholar
• Levi S, Rovida E. 2009. The role of iron in mitochondrial function. Biochim Biophys Acta. 1790(7):629–636. doi: 10.1016/j.bbagen.2008.09.008.
   PubMed Web of Science ®Google Scholar
• Li X, Dai J, Tang Y, Li L, Jin G. 2017. Quantitative proteomic profiling of tachyplesin i targets in U251 gliomaspheres. Mar Drugs. 15(1):20. doi: 10.3390/md15010020.
   PubMed Web of Science ®Google Scholar
• Lima T, Bernfur K, Vilanova M, Cedervall T. 2020. Understanding the lipid and protein corona formation on different sized polymeric nanoparticles. Sci Rep. 10(1):1129. doi: 10.1038/s41598-020-57943-6.
   PubMed Web of Science ®Google Scholar
• Lin YM, Ghosh M, Miller PA, Möllmann U, Miller MJ. 2019. Synthetic sideromycins (skepticism and optimism): selective generation of either broad or narrow spectrum gram-negative antibiotics. Biometals. 32(3):425–451. doi: 10.1007/s10534-019-00192-6.
   PubMed Web of Science ®Google Scholar
• Ling H, Lou X, Luo Q, He Z, Sun M, Sun J. 2022. Recent advances in bacteriophage-based therapeutics: insight into the post-antibiotic era. Acta Pharm Sin B. 12(12):4348–4364. doi: 10.1016/j.apsb.2022.05.007.
   PubMed Web of Science ®Google Scholar
• Lin Z, Xu X, Zhao S, Yang X, Guo J, Zhang Q, Jing C, Chen S, He Y. 2018. Total synthesis and antimicrobial evaluation of natural albomycins against clinical pathogens. Nat Commun. 9(1):3445. doi: 10.1038/s41467-018-05821-1.
   PubMedGoogle Scholar
• Li W, O’Brien-Simpson NM, Holden JA, Otvos L, Reynolds EC, Separovic F, Hossain MA, Wade JD. 2018. Covalent conjugation of cationic antimicrobial peptides with a β-lactam antibiotic core. Pept Sci. 110(3):210. doi: 10.1002/pep2.24059
   Web of Science ®Google Scholar
• Lipkin R, Lazaridis T. 2017. Computational studies of peptide-induced membrane pore formation. Phil Trans R Soc B. 372(1726):20160219. doi: 10.1098/rstb.2016.0219.
   PubMed Web of Science ®Google Scholar
• Li H, Qian ZM. 2002. Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev. 22(3):225–250. doi: 10.1002/med.10008.
   PubMed Web of Science ®Google Scholar
• Liu R, Miller PA, Vakulenko SB, Stewart NK, Boggess WC, Miller MJ. 2018. A synthetic dual drug sideromycin induces gram-negative bacteria to commit suicide with a gram-positive antibiotic. J Med Chem. 61(9):3845–3854. doi: 10.1021/acs.jmedchem.8b00218.
   PubMed Web of Science ®Google Scholar
• Loh B, Gondil VS, Manohar P, Khan FM, Yang H, Leptihn S. 2021. Encapsulation and delivery of therapeutic phages. Appl Environ Microbiol. 87(5):e01979-20. doi: 10.1128/AEM.01979-20.
   PubMed Web of Science ®Google Scholar
• Lopatkin AJ, Bening SC, Manson AL, Stokes JM, Kohanski MA, Badran AH, Earl AM, Cheney NJ, Yang JH, Collins JJ. 2021. Clinically relevant mutations in core metabolic genes confer antibiotic resistance. Science. 371(6531):eaba0862. doi: 10.1126/science.aba0862.
   PubMed Web of Science ®Google Scholar
• Lv Y, Su L, Zhao Z, Zhao J, Su H, Zhang Z, Wang Y. 2023. Chitosan microspheres loaded with curcumin and gallic acid: modified synthesis, sustainable slow release, and enhanced biological property. Curr Microbiol. 80(8):240. doi: 10.1007/s00284-023-03352-7.
   PubMed Web of Science ®Google Scholar
• MacDougall G, Anderton RS, Edwards AB, Knuckey NW, Meloni BP. 2017. The neuroprotective peptide poly-arginine-12 (R12) reduces cell surface levels of NMDA NR2B receptor subunit in cortical neurons; investigation into the involvement of endocytic mechanisms. J Mol Neurosci. 61(2):235–246. doi: 10.1007/s12031-016-0861-1.
   PubMed Web of Science ®Google Scholar
• Macyszyn J, Chyży P, Burmistrz M, Lobka M, Miszkiewicz J, Wojciechowska M, Trylska J. 2023. Structural dynamics influences the antibacterial activity of a cell-penetrating peptide (KFF)3K. Sci Rep. 13(1):14826. doi: 10.1038/s41598-023-38745-y.
   PubMed Web of Science ®Google Scholar
• Makabenta JMV, Nabawy A, Li CH, Schmidt-Malan S, Patel R, Rotello VM. 2021. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nat Rev Microbiol. 19(1):23–36. doi: 10.1038/s41579-020-0420-1.
   PubMed Web of Science ®Google Scholar
• Makowski M, Silva ÍC, Do Amaral CP, Gonçalves S, Santos NC. 2019. Advances in lipid and metal nanoparticles for antimicrobial peptide delivery. Pharmaceutics. 11(11):588. doi: 10.3390/pharmaceutics11110588.
   PubMed Web of Science ®Google Scholar
• Manea YK, Qashqoosh MTA, Rezakazemi M. 2024. In vitro hemoglobin binding and molecular docking of synthesized chitosan-based drug-carrying nanocomposite for ciprofloxacin-HCl drug delivery system. ACS Omega. 9(6):6339–6354. doi: 10.1021/acsomega.3c04632.
   PubMed Web of Science ®Google Scholar
• Mangal S, Ranot N, Nosran A, Singh V, Chhibber S, Harjai K. 2023. In vivo efficacy of pyochelin-mediated delivery of zingerone in Pseudomonas aeruginosa-induced peritonitis. Future Microbiol. 18:1339–1351. doi: 10.2217/fmb-2023-0016.
   PubMedGoogle Scholar
• Mariathasan S, Tan MW. 2017. Antibody–antibiotic conjugates: a novel therapeutic platform against bacterial infections. Trends Mol Med. 23(2):135–149. doi: 10.1016/j.molmed.2016.12.008.
   PubMed Web of Science ®Google Scholar
• Mashburn LM, Jett AM, Akins DR, Whiteley M. 2005. Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture. J Bacteriol. 187(2):554–566. doi: 10.1128/JB.187.2.554-566.2005.
   PubMed Web of Science ®Google Scholar
• Massip C, Oswald E. 2020. Siderophore-microcins in Escherichia coli: determinants of digestive colonization, the first step toward virulence. Front Cell Infect Microbiol. 10:381. doi: 10.3389/fcimb.2020.00381.
   PubMed Web of Science ®Google Scholar
• Ma J, Sun H, Li B, Wu B, Zhang X, Ye L. 2024. Horizontal transfer potential of antibiotic resistance genes in wastewater treatment plants unraveled by microfluidic-based mini-metagenomics. J Hazard Mater. 465:133493. doi: 10.1016/j.jhazmat.2024.133493.
   PubMedGoogle Scholar
• Matijass M, Neundorf I. 2021. Cell-penetrating peptides as part of therapeutics used in cancer research. Med Drug Discov. 10:100092. doi: 10.1016/j.medidd.2021.100092.
   Google Scholar
• Ma L, Xie X, Liu H, Huang Y, Wu H, Jiang M, Xu P, Ye X, Zhou C. 2020. Potent antibacterial activity of MSI-1 derived from the magainin 2 peptide against drug-resistant bacteria. Theranostics. 10(3):1373–1390. doi: 10.7150/thno.39157.
   PubMed Web of Science ®Google Scholar
• Mayor S, Pagano RE. 2007. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol. 8(8):603–612. doi: 10.1038/nrm2216.
   PubMed Web of Science ®Google Scholar
• McPherson CJ, Aschenbrenner LM, Lacey BM, Fahnoe KC, Lemmon MM, Finegan SM, Tadakamalla B, O’Donnell JP, Mueller JP, Tomaras AP. 2012. Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam. Antimicrob Agents Chemother. 56(12):6334–6342. doi: 10.1128/AAC.01345-12.
   PubMed Web of Science ®Google Scholar
• Meléndez-Alafort L, Nadali A, Pasut G, Zangoni E, De Caro R, Cariolato L, Giron MC, Castagliuolo I, Veronese FM, Mazzi U. 2009. Detection of sites of infection in mice using 99mTc-labeled PN2S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study. Nucl Med Biol. 36(1):57–64. doi: 10.1016/j.nucmedbio.2008.10.011.
   PubMed Web of Science ®Google Scholar
• Members IUSS. 2011. Acinetobacter baumannii Infections among Patients at Military Medical Facilities Treating. 53(45):1–5.
   Google Scholar
• Meng X, Xu Z, Wang C, Patitz J, Boccaccini AR, Burkovski A, Zheng K. 2024. Surface engineering of mesoporous bioactive glass nanoparticles with bacteriophages for enhanced antibacterial activity. Colloids Surf B Biointerfaces. 234:113714. doi: 10.1016/j.colsurfb.2023.113714.
   PubMed Web of Science ®Google Scholar
• Merchant B. 1998. Gold, the Noble metal and the paradoxes of its toxicology. Biologicals. 26(1):49–59. doi: 10.1006/biol.1997.0123.
   PubMed Web of Science ®Google Scholar
• Miethke M, Marahiel MA. 2007. Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev. 71(3):413–451. doi: 10.1128/MMBR.00012-07.
   PubMed Web of Science ®Google Scholar
• Miller MJ. 1989. Syntheses and therapeutic potential of hydroxamic acid based siderophores and analogues. Chem Rev. 89(7):1563–1579. doi: 10.1021/cr00097a011.
   Web of Science ®Google Scholar
• Miller MJ, Malouin F. 1993. Microbial iron chelators as drug delivery agents: the rational design and synthesis of siderophore-drug conjugates. Acc Chem Res. 26(5):241–249. doi: 10.1021/ar00029a003.
   Web of Science ®Google Scholar
• Miller MJ, Walz AJ, Zhu H, Wu C, Moraski G, Möllmann U, Tristani EM, Crumbliss AL, Ferdig MT, Checkley L, et al. 2011. Design, synthesis, and study of a mycobactin − artemisinin conjugate that has selective and potent activity against tuberculosis and malaria. J Am Chem Soc. 133(7):2076–2079.,. doi: 10.1021/ja109665t.
   PubMed Web of Science ®Google Scholar
• Miller KP, Wang L, Benicewicz BC, Decho AW. 2015. Inorganic nanoparticles engineered to attack bacteria. Chem Soc Rev. 44(21):7787–7807. doi: 10.1039/c5cs00041f.
   PubMed Web of Science ®Google Scholar
• Miranda Calderon LG, Alejo T, Santos S, Mendoza G, Irusta S, Arruebo M. 2023. Antibody-functionalized polymer nanoparticles for targeted antibiotic delivery in models of pathogenic bacteria infecting human macrophages. acs Appl Mater Interfaces. 15(34):40213–40227. doi: 10.1021/acsami.3c07367.
   PubMed Web of Science ®Google Scholar
• Mishra NM, Briers Y, Lamberigts C, Steenackers H, Robijns S, Landuyt B, Vanderleyden J, Schoofs L, Lavigne R, Luyten W, et al. 2015. Evaluation of the antibacterial and antibiofilm activities of novel CRAMP-vancomycin conjugates with diverse linkers. Org Biomol Chem. 13(27):7477–7486. doi: 10.1039/c5ob00830a.
   PubMed Web of Science ®Google Scholar
• Mnif S, Jardak M, Graiet I, Abid S, Driss D, Kharrat N. 2019. The novel cationic cell-penetrating peptide PEP-NJSM is highly active against Staphylococcus epidermidis biofilm. Int J Biol Macromol. 125:262–269. doi: 10.1016/j.ijbiomac.2018.12.008.
   PubMed Web of Science ®Google Scholar
• Mohamed MF, Brezden A, Mohammad H, Chmielewski J, Seleem MN. 2017. Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate. Biochim Biophys Acta Gen Subj. 1861(4):848–859. doi: 10.1016/j.bbagen.2017.01.029.
   PubMed Web of Science ®Google Scholar
• Mohs RC, Greig NH. 2017. Drug discovery and development: role of basic biological research. Alzheimers Dement (N Y). 3(4):651–657. doi: 10.1016/j.trci.2017.10.005.
   PubMedGoogle Scholar
• Möllmann U, Heinisch L, Bauernfeind A, Köhler T, Ankel-Fuchs D. 2009. Siderophores as drug delivery agents: application of the “trojan Horse” strategy. Biometals. 22(4):615–624. doi: 10.1007/s10534-009-9219-2.
   PubMed Web of Science ®Google Scholar
• Monteiro N, Martins M, Martins A, Fonseca NA, Moreira JN, Reis RL, Neves NM. 2015. Antibacterial activity of chitosan nanofiber meshes with liposomes immobilized releasing gentamicin. Acta Biomater. 18:196–205. doi: 10.1016/j.actbio.2015.02.018.
   PubMed Web of Science ®Google Scholar
• Mortezaee K, Najafi M, Samadian H, Barabadi H, Azarnezhad A, Ahmadi A. 2019. Redox interactions and genotoxicity of metal-based nanoparticles: a comprehensive review. Chem Biol Interact. 312:108814. doi: 10.1016/j.cbi.2019.108814.
   PubMed Web of Science ®Google Scholar
• Mugabe C, Halwani M, Azghani AO, Lafrenie RM, Omri A. 2006. Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 50(6):2016–2022. doi: 10.1128/AAC.01547-05.
   PubMed Web of Science ®Google Scholar
• Mühlberg E, Umstätter F, Domhan C, Hertlein T, Ohlsen K, Krause A, Kleist C, Beijer B, Zimmermann S, Haberkorn U, et al. 2020. Vancomycin-lipopeptide conjugates with high antimicrobial activity on vancomycin-resistant enterococci. Pharmaceuticals. 13(6):110. doi: 10.3390/ph13060110.
   Web of Science ®Google Scholar
• Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, et al. 2022. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 399(10325):629–655. doi: 10.1016/S0140-6736(21)02724-0.
   PubMed Web of Science ®Google Scholar
• Nagoba B, Vedpathak D. 2011. Medical applications of siderophores. Electron J Gen Med. 8(3):229–235. doi: 10.29333/ejgm/82743.
   Google Scholar
• Nakase I, Hirose H, Tanaka G, Tadokoro A, Kobayashi S, Takeuchi T, Futaki S. 2009. Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis. Mol Ther. 17(11):1868–1876. doi: 10.1038/mt.2009.192.
   PubMed Web of Science ®Google Scholar
• Nakonieczna A, Topolska-Woś A, Łobocka M. 2024. New bacteriophage-derived lysins, LysJ and LysF, with the potential to control Bacillus anthracis. Appl Microbiol Biotechnol. 108(1):76. doi: 10.1007/s00253-023-12839-z.
   PubMedGoogle Scholar
• Negash KH, Norris JKS, Hodgkinson JT. 2019. Siderophore–antibiotic conjugate design: new drugs for bad bugs? Molecules. 24(18):3314. doi: 10.3390/molecules24183314.
   PubMed Web of Science ®Google Scholar
• Nepal A, Ræder SB, Søgaard CK, Haugan MS, Otterlei M. 2021. Broad-spectrum antibacterial peptide kills extracellular and intracellular bacteria without affecting epithelialization. Front Microbiol. 12:764451. doi: 10.3389/fmicb.2021.764451.
   PubMed Web of Science ®Google Scholar
• Neumann W, Nolan EM. 2018. Evaluation of a reducible disulfide linker for siderophore-mediated delivery of antibiotics. J Biol Inorg Chem. 23(7):1025–1036. doi: 10.1007/s00775-018-1588-y.
   PubMed Web of Science ®Google Scholar
• Nguyen LT, Haney EF, Vogel HJ. 2011. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 29(9):464–472. doi: 10.1016/j.tibtech.2011.05.001.
   PubMed Web of Science ®Google Scholar
• Nobrega FL, Vlot M, de Jonge PA, Dreesens LL, Beaumont HJE, Lavigne R, Dutilh BE, Brouns SJJ. 2018. Targeting mechanisms of tailed bacteriophages. Nat Rev Microbiol. 16(12):760–773. doi: 10.1038/s41579-018-0070-8.
   PubMed Web of Science ®Google Scholar
• Nuding S, Frasch T, Schaller M, Stange EF, Zabel LT. 2014. Synergistic effects of antimicrobial peptides and antibiotics against clostridium difficile. Antimicrob Agents Chemother. 58(10):5719–5725. doi: 10.1128/AAC.02542-14.
   PubMed Web of Science ®Google Scholar
• Oehlke J, Scheller A, Wiesner B, Krause E, Beyermann M, Klauschenz E, Melzig M, Bienert M. 1998. Cellular uptake of an α-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim Biophys Acta. 1414(1-2):127–139. doi: 10.1016/s0005-2736(98)00161-8.
   PubMed Web of Science ®Google Scholar
• Okkeh M, Bloise N, Restivo E, De Vita L, Pallavicini P, Visai L. 2021. Gold nanoparticles: can they be the next magic bullet for multidrug-resistant bacteria? Nanomaterials. 11(2):312. doi: 10.3390/nano11020312.
   Web of Science ®Google Scholar
• Olshvang E, Fritsch S, Scholtyssek OC, Schalk IJ, Metzler-Nolte N. 2023. Vectorization via siderophores increases antibacterial activity of K(RW)(3) peptides against Pseudomonas aeruginosa. Chemistry. 29(50):e202300364. doi: 10.1002/chem.202300364
   PubMed Web of Science ®Google Scholar
• Oromí-Bosch A, Antani JD, Turner PE. 2023. Developing phage therapy that overcomes the evolution of bacterial resistance. Annu Rev Virol. 10(1):503–524. doi: 10.1146/annurev-virology-012423-110530.
   PubMedGoogle Scholar
• Paech F, Messner S, Spickermann J, Wind M, Schmitt-Hoffmann A-H, Witschi AT, Howell BA, Church RJ, Woodhead J, Engelhardt M, et al. 2017. Mechanisms of hepatotoxicity associated with the monocyclic β-lactam antibiotic BAL30072. Arch Toxicol. 91(11):3647–3662.,. doi: 10.1007/s00204-017-1994-x.
   PubMed Web of Science ®Google Scholar
• Page MGP, Dantier C, Desarbre E. 2010. In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli. Antimicrob Agents Chemother. 54(6):2291–2302. doi: 10.1128/AAC.01525-09.
   PubMed Web of Science ®Google Scholar
• Palau M, Muñoz E, Gusta MF, Larrosa N, Gomis X, Gilabert J, Almirante B, Puntes V, Texidó R, Gavaldà J. 2023. In vitro antibacterial activity of silver nanoparticles conjugated with amikacin and combined with hyperthermia against drug-resistant and biofilm-producing strains. Microbiol Spectr. 11(3):e0028023. doi: 10.1128/spectrum.00280-23.
   PubMed Web of Science ®Google Scholar
• Panáček A, Kvítek L, Smékalová M, Večeřová R, Kolář M, Röderová M, Dyčka F, Šebela M, Prucek R, Tomanec O, et al. 2018. Bacterial resistance to silver nanoparticles and how to overcome it. Nat Nanotechnol. 13(1):65–71. doi: 10.1038/s41565-017-0013-y.
   PubMed Web of Science ®Google Scholar
• Pandey A, Śmiłowicz D, Boros E. 2021. Galbofloxacin: a xenometal-antibiotic with potentin vitroandin vivoefficacy againstS. aureus. Chem Sci. 12(43):14546–14556. doi: 10.1039/d1sc04283a.
   PubMedGoogle Scholar
• Park YJ, Chang L-C, Liang JF, Moon C, Chung C-P, Yang VC. 2005. Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: in vitro and in vivo study. Faseb J. 19(11):1555–1557. doi: 10.1096/fj.04-2322fje.
   PubMedGoogle Scholar
• Park HY, Chung C, Eiken MK, Baumgartner KV, Fahy KM, Leung KQ, Bouzos E, Asuri P, Wheeler KE, Riley KR. 2023. Silver nanoparticle interactions with glycated and non-glycated human serum albumin mediate toxicity. Front Toxicol. 5:1081753. doi: 10.3389/ftox.2023.1081753.
   PubMedGoogle Scholar
• Park CB, Kim MS, Kim SC. 1996. A novel antimicrobial peptide from Bufo bufo gargarizans. Biochem Biophys Res Commun. 218(1):408–413. doi: 10.1006/bbrc.1996.0071.
   PubMed Web of Science ®Google Scholar
• Park SE, Sajid MI, Parang K, Tiwari RK. 2019. Cyclic cell-penetrating peptides as efficient intracellular drug delivery tools. Mol Pharm. 16(9):3727–3743. doi: 10.1021/acs.molpharmaceut.9b00633.
   PubMedGoogle Scholar
• Patel MB, Garrad E, Meisel JW, Negin S, Gokel MR, Gokel GW. 2019. Synthetic ionophores as non-resistant antibiotic adjuvants. RSC Adv. 9(4):2217–2230. doi: 10.1039/c8ra07641c.
   PubMed Web of Science ®Google Scholar
• Pawar V, Dhanka M, Srivastava R. 2019. Cefuroxime conjugated chitosan hydrogel for treatment of wound infections. Colloids Surf B Biointerfaces. 173:776–787. doi: 10.1016/j.colsurfb.2018.10.034.
   PubMed Web of Science ®Google Scholar
• Payne SM, Neilands IB. 1988. Iron and virulence in the family enterobacteriaceae. Crit Rev Microbiol. 16(2):81–111. doi: 10.3109/10408418809104468.
   PubMed Web of Science ®Google Scholar
• Peukert C, Vetter AC, Fuchs HLS, Harmrolfs K, Karge B, Stadler M, Brönstrup M. 2023. Siderophore conjugation with cleavable linkers boosts the potency of RNA polymerase inhibitors against multidrug-resistant E. coli. Chem. Sci. 14(20):5490–5502. doi: 10.1039/d2sc06850h.
   PubMed Web of Science ®Google Scholar
• Pfeifer E, Bonnin RA, Rocha EPC. 2022. Phage-plasmids spread antibiotic resistance genes through infection and lysogenic conversion. MBio. 13(5):e0185122. doi: 10.1128/mbio.01851-22.
   PubMed Web of Science ®Google Scholar
• Plota M, Sazakli E, Giormezis N, Gkartziou F, Kolonitsiou F, Leotsinidis M, Antimisiaris SG, Spiliopoulou I. 2021. In vitro anti-biofilm activity of bacteriophage k (Atcc 19685-b1) and daptomycin against staphylococci. Microorganisms. 9(9):1853. doi: 10.3390/microorganisms9091853.
   PubMed Web of Science ®Google Scholar
• Ponnappan N, Budagavi DP, Chugh A. 2017. CyLoP-1: membrane-active peptide with cell-penetrating and antimicrobial properties. Biochim Biophys Acta Biomembr. 1859(2):167–176. doi: 10.1016/j.bbamem.2016.11.002.
   PubMed Web of Science ®Google Scholar
• Pooga M, Hällbrink M, Zorko M, Langel U. 1998. Cell penetration by transportan. Faseb J. 12(1):67–77. doi: 10.1096/fasebj.12.1.67.
   PubMed Web of Science ®Google Scholar
• Popescu M, Van Belleghem JD, Khosravi A, Bollyky PL. 2021. Bacteriophages and the Immune System. Annu Rev Virol. 8(1):415–435. doi: 10.1146/annurev-virology-091919-074551.
   PubMedGoogle Scholar
• Porosk L, Gaidutšik I, Langel Ü. 2021. Approaches for the discovery of new cell-penetrating peptides. Expert Opin Drug Discov. 16(5):553–565. doi: 10.1080/17460441.2021.1851187.
   PubMed Web of Science ®Google Scholar
• Post SJ, Shapiro JA, Wuest WM. 2019. Connecting iron acquisition and biofilm formation in the ESKAPE pathogens as a strategy for combatting antibiotic resistance. Medchemcomm. 10(4):505–512. doi: 10.1039/c9md00032a.
   PubMed Web of Science ®Google Scholar
• Pouny Y, Rapaport D, Mor A, Nicolas P, Shai Y. 1992. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry. 31(49):12416–12423. doi: 10.1021/bi00164a017.
   PubMed Web of Science ®Google Scholar
• Prasad NK, Seiple IB, Cirz RT, Rosenberg OS. 2022. Leaks in the pipeline: a failure analysis of gram-negative antibiotic development from 2010 to 2020. Antimicrob Agents Chemother. 66(5):e0005422. doi: 10.1128/aac.00054-22.
   PubMed Web of Science ®Google Scholar
• Pujals S, Fernández-Carneado J, Ludevid MD, Giralt E. 2008. A new, noncytotoxic, and fully protease resistant cell-penetrating peptide. ChemMedChem. 3(2):296–301. doi: 10.1002/cmdc.200700267.
   PubMed Web of Science ®Google Scholar
• Qin L, Hu N, Zhang Y, Yang L, Zhang X, Yang Y, Zhang J, Zou Y, Wei K, Zhao C, et al. 2023. Antibody-antibiotic conjugate targeted therapy for orthopedic implant-associated intracellular S. aureus infections. J. Adv. Res. S2090-1232(23):00375–00372. doi: 10.1016/j.jare.2023.12.001.
   Google Scholar
• Radek K, Gallo R. 2007. Antimicrobial peptides: natural effectors of the innate immune system. Semin Immunopathol. 29(1):27–43. doi: 10.1007/s00281-007-0064-5.
   PubMed Web of Science ®Google Scholar
• Randhawa HK, Gautam A, Sharma M, Bhatia R, Varshney GC, Raghava GPS, Nandanwar H. 2016. Cell-penetrating peptide and antibiotic combination therapy: a potential alternative to combat drug resistance in methicillin-resistant Staphylococcus aureus. Appl Microbiol Biotechnol. 100(9):4073–4083. doi: 10.1007/s00253-016-7329-7.
   PubMed Web of Science ®Google Scholar
• Rathnayake K, Patel U, Pham C, McAlpin A, Budisalich T, Jayawardena SN. 2020. Targeted delivery of antibiotic therapy to inhibit Pseudomonas aeruginosa using lipid-coated mesoporous silica core-shell nanoassembly. ACS Appl Bio Mater. 3(10):6708–6721. doi: 10.1021/acsabm.0c00622.
   PubMedGoogle Scholar
• Ratledge C, Dover LG. 2000. Iron metabolism in pathogenic bacteria. Annu Rev Microbiol. 54(1):881–941. doi: 10.1146/annurev.micro.54.1.881.
   PubMedGoogle Scholar
• Ratliff AC, Buchanan SK, Celia H. 2022. The Ton Motor. Front Microbiol. 13:852955. doi: 10.3389/fmicb.2022.852955.
   PubMed Web of Science ®Google Scholar
• Raymond KN, Allred BE, Sia AK. 2015. Coordination chemistry of microbial iron transport. Acc Chem Res. 48(9):2496–2505. doi: 10.1021/acs.accounts.5b00301.
   PubMed Web of Science ®Google Scholar
• Rhomberg PR, Shortridge D, Huband MD, Butler D, West J, Flamm RK. 2017. Multilaboratory broth microdilution MIC reproducibility study for GSK3342830, a novel catechol-cephem, abstr SATURDAY287. ASM Microbe. (1):1.
   Google Scholar
• Rodriguez CA, Papanastasiou EA, Juba M, Bishop B. 2014. Covalent modification of a ten-residue cationic antimicrobial peptide with levofloxacin. Front Chem. 2:71. doi: 10.3389/fchem.2014.00071.
   PubMed Web of Science ®Google Scholar
• Rodríguez D, González-Bello C. 2023. Siderophores: chemical tools for precise antibiotic delivery. Bioorg Med Chem Lett. 87:129282. doi: 10.1016/j.bmcl.2023.129282.
   PubMed Web of Science ®Google Scholar
• Roosenberg JM, 2nd, Lin YM, Lu Y, Miller MJ. 2000. Studies and syntheses of siderophores, microbial iron chelators, and analogs as potential drug delivery agents. Curr Med Chem. 7(2):159–197. doi: 10.2174/0929867003375353.
   PubMed Web of Science ®Google Scholar
• Ruczyński J, Rusiecka I, Turecka K, Kozłowska A, Alenowicz M, Gągało I, Kawiak A, Rekowski P, Waleron K, Kocić I. 2019. Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin. Sci Rep. 9(1):3247. doi: 10.1038/s41598-019-40103-w.
   PubMedGoogle Scholar
• Rudilla H, Fusté E, Cajal Y, Rabanal F, Vinuesa T, Viñas M. 2016. Synergistic antipseudomonal effects of synthetic peptide AMP38 and carbapenems. Molecules. 21(9):1223. doi: 10.3390/molecules21091223.
   PubMed Web of Science ®Google Scholar
• Sabaeifard P, Abdi-Ali A, Gamazo C, Irache JM, Reza Soudi M. 2017. Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa. J Med Microbiol. 66(2):137–148. doi: 10.1099/jmm.0.000430.
   PubMed Web of Science ®Google Scholar
• Saha R, Saha N, Donofrio RS, Bestervelt LL. 2013. Microbial siderophores: a mini review. J Basic Microbiol. 53(4):303–317. doi: 10.1002/jobm.201100552.
   PubMed Web of Science ®Google Scholar
• Sahasathian T, Kerdcholpetch T, Chanweroch A, Praphairaksit N, Suwonjandee N, Muangsin N. 2007. Sustained release of amoxicillin from chitosan tablets. Arch Pharm Res. 30(4):526–531. doi: 10.1007/BF02980229.
   PubMed Web of Science ®Google Scholar
• Sahiner M, Yilmaz AS, Ayyala RS, Sahiner N. 2023. Carboxymethyl chitosan microgels for sustained delivery of vancomycin and long-lasting antibacterial effects. Gels. 9(9):708. doi: 10.3390/gels9090708.
   PubMed Web of Science ®Google Scholar
• Sánchez-López E, Gomes D, Esteruelas G, Bonilla L, Lopez-Machado AL, Galindo R, Cano A, Espina M, Ettcheto M, Camins A, et al. 2020. Metal-based nanoparticles as antimicrobial agents: an overview. Nanomaterials. 10(2):292. doi: 10.3390/nano10020292.
   Web of Science ®Google Scholar
• Sargun A, Johnstone TC, Zhi H, Raffatellu M, Nolan EM. 2021. Enterobactin- and salmochelin-β-lactam conjugates induce cell morphologies consistent with inhibition of penicillin-binding proteins in uropathogenicEscherichia coliCFT073. Chem Sci. 12(11):4041–4056. doi: 10.1039/d0sc04337k.
   PubMed Web of Science ®Google Scholar
• Sarma PP, Rai A, Baruah PK. 2024. Recent advances in the development of antibiotics-coated gold nanoparticles to combat antimicrobial resistance. Antibiotics. 13(2):124. doi: 10.3390/antibiotics13020124.
   Google Scholar
• Sato T, Yamawaki K. 2019. Cefiderocol: discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin. Clin Infect Dis. 69(Suppl 7):S538–S543. doi: 10.1093/cid/ciz826.
   PubMedGoogle Scholar
• Schaenzer AJ, Wright GD. 2020. Antibiotic resistance by enzymatic modi fi cation of antibiotic targets. Trends Mol Med. 26(8):768–782. doi: 10.1016/j.molmed.2020.05.001.
   PubMed Web of Science ®Google Scholar
• Schalk IJ. 2018. Siderophore–antibiotic conjugates: exploiting iron uptake to deliver drugs into bacteria. Clin Microbiol Infect. 24(8):801–802. doi: 10.1016/j.cmi.2018.03.037.
   PubMed Web of Science ®Google Scholar
• Scheeder A, Brockhoff M, Ward EN, Kaminski Schierle GS, Mela I, Kaminski CF. 2023. Molecular Mechanisms of Cationic Fusogenic Liposome Interactions with Bacterial Envelopes. J Am Chem Soc. 145(51):28240–28250. doi: 10.1021/jacs.3c11463.
   PubMed Web of Science ®Google Scholar
• Schiffelers RM, Storm G, Ten Kate MT, Bakker-Woudenberg IAJM. 2001. Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin. Antimicrob Agents Chemother. 45(2):464–470. doi: 10.1128/AAC.45.2.464-470.2001.
   PubMed Web of Science ®Google Scholar
• Schwarze SR, Hruska KA, Dowdy SF. 2000. Protein transduction: unrestricted delivery into all cells? Trends Cell Biol. 10(7):290–295. 2 doi: 10.1016/s0962-8924(00)01771-2.
   PubMed Web of Science ®Google Scholar
• Scriboni AB, Couto VM, De Morais Ribeiro LN, Freires IA, Groppo FC, De Paula E, Franz-Montan M, Cogo-Müller K. 2019. Fusogenic liposomes increase the antimicrobial activity of vancomycin against staphylococcus aureus biofilm. Front Pharmacol. 10:1401. doi: 10.3389/fphar.2019.01401.
   PubMed Web of Science ®Google Scholar
• Shaaban MI, Shaker MA, Mady FM. 2017. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates. J Nanobiotechnology. 15(1):29. doi: 10.1186/s12951-017-0262-9.
   PubMedGoogle Scholar
• Shankar P. 2016. Book review: tackling drug-resistant infections globally. Arch Pharma Pract. 7(3):110–111. doi: 10.4103/2045-080X.186181.
   Web of Science ®Google Scholar
• Shariati A, Chegini Z, Ghaznavi-Rad E, Zare EN, Hosseini SM. 2022. PLGA-based nanoplatforms in drug delivery for inhibition and destruction of microbial biofilm. Front Cell Infect Microbiol. 12:926363. doi: 10.3389/fcimb.2022.926363.
   PubMed Web of Science ®Google Scholar
• Sharma A, Kumar Arya D, Dua M, Chhatwal GS, Johri AK. 2012. Nano-technology for targeted drug delivery to combat antibiotic resistance. Expert Opin Drug Deliv. 9(11):1325–1332. doi: 10.1517/17425247.2012.717927.
   PubMed Web of Science ®Google Scholar
• Shirley M. 2019. Amikacin liposome inhalation suspension: a review in mycobacterium avium complex lung disease. Drugs. 79(5):555–562. doi: 10.1007/s40265-019-01095-z.
   PubMed Web of Science ®Google Scholar
• Shukla RK, Badiye A, Vajpayee K, Kapoor N. 2021. Genotoxic potential of nanoparticles: structural and functional modifications in DNA. Front Genet. 12:728250. doi: 10.3389/fgene.2021.728250.
   PubMed Web of Science ®Google Scholar
• Sim S, Wang P, Beyer BN, Cutrona KJ, Radhakrishnan ML, Elmore DE. 2017. Investigating the nucleic acid interactions of histone-derived antimicrobial peptides. FEBS Lett. 591(5):706–717. doi: 10.1002/1873-3468.12574.
   PubMed Web of Science ®Google Scholar
• Simon MJ, Kang WH, Gao S, Banta S, Morrison B. 2011. TAT is not capable of transcellular delivery across an intact endothelial monolayer in vitro. Ann Biomed Eng. 39(1):394–401. doi: 10.1007/s10439-010-0144-x.
   PubMed Web of Science ®Google Scholar
• Simon MJ, Kang WH, Gao S, Banta S, Morrison B.III 2010. Increased delivery of TAT across an endothelial monolayer following ischemic injury. Neurosci Lett. 486(1):1–4. doi: 10.1016/j.neulet.2010.09.029.
   PubMed Web of Science ®Google Scholar
• Simsekli O, Bilinmis I, Celik S, Arık G, Baba AY, Karakucuk A. 2023. Advancing biofilm management through nanoformulation strategies: a review of dosage forms and administration routes. J Drug Target. 31(9):931–949. doi: 10.1080/1061186X.2023.2270619.
   PubMed Web of Science ®Google Scholar
• Slavin YN, Asnis J, Häfeli UO, Bach H. 2017. Metal nanoparticles: understanding the mechanisms behind antibacterial activity. J Nanobiotechnology. 15(1):65. doi: 10.1186/s12951-017-0308-z.
   PubMed Web of Science ®Google Scholar
• Snyder EL, Dowdy SF. 2004. Cell penetrating peptides in drug delivery. Pharm Res. 21(3):389–393. doi: 10.1023/B:PHAM.0000019289.61978.f5.
   PubMed Web of Science ®Google Scholar
• Soe YM, Bedoui S, Stinear TP. 2021. Intracellular Staphylococcus aureus and host cell death pathways. Cell Microbiol. 23(5):e13317. doi: 10.1111/cmi.13317
   PubMed Web of Science ®Google Scholar
• Stabryla LM, Johnston KA, Diemler NA, Cooper VS, Millstone JE, Haig SJ, Gilbertson LM. 2021. Role of bacterial motility in differential resistance mechanisms of silver nanoparticles and silver ions. Nat Nanotechnol. 16(9):996–1003. doi: 10.1038/s41565-021-00929-w.
   PubMed Web of Science ®Google Scholar
• Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM. 2019. Positive charge patterning and hydrophobicity of membrane-active antimicrobial peptides as determinants of activity, toxicity, and pharmacokinetic stability. J Med Chem. 62(13):6276–6286. doi: 10.1021/acs.jmedchem.9b00657.
   PubMed Web of Science ®Google Scholar
• Subramaniam S, Joyce P, Thomas N, Prestidge CA. 2021. Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections. Adv Drug Deliv Rev. 177:113948. doi: 10.1016/j.addr.2021.113948.
   PubMed Web of Science ®Google Scholar
• Su Z, Xiao D, Xie F, Liu L, Wang Y, Fan S, Zhou X, Li S. 2021. Antibody–drug conjugates: recent advances in linker chemistry. Acta Pharm Sin B. 11(12):3889–3907. doi: 10.1016/j.apsb.2021.03.042.
   PubMed Web of Science ®Google Scholar
• Su D, Zhang D. 2021. Linker design impacts antibody-drug conjugate pharmacokinetics and efficacy via modulating the stability and payload release efficiency. Front Pharmacol. 12:687926. doi: 10.3389/fphar.2021.687926.
   PubMed Web of Science ®Google Scholar
• Swayambhu G, Bruno M, Gulick AM, Pfeifer BA. 2021. Siderophore natural products as pharmaceutical agents. Curr Opin Biotechnol. 69:242–251. doi: 10.1016/j.copbio.2021.01.021.
   PubMed Web of Science ®Google Scholar
• Swedan S, Shubair Z, Almaaytah A. 2019. Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae. Infect Drug Resist. 12:2019–2030. doi: 10.2147/IDR.S215084.
   PubMed Web of Science ®Google Scholar
• Taheri-Ledari R, Ahghari MR, Ansari F, Forouzandeh-Malati M, Mirmohammadi SS, Zarei-Shokat S, Ramezanpour S, Zhang W, Tian Y, Maleki A. 2022. Synergies in antimicrobial treatment by a levofloxacin-loaded halloysite and gold nanoparticles with a conjugation to a cell-penetrating peptide. Nanoscale Adv. 4(20):4418–4433. doi: 10.1039/d2na00431c.
   PubMed Web of Science ®Google Scholar
• Tamma PD, Cosgrove SE, Maragakis LL. 2012. Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev. 25(3):450–470. doi: 10.1128/CMR.05041-11.
   PubMed Web of Science ®Google Scholar
• Tang X, Yu P, Tang L, Zhou M, Fan C, Lu Y, Mathieu J, Xiong W, Alvarez PJ. 2019. Bacteriophages from arsenic-resistant bacteria transduced resistance genes, which changed arsenic speciation and increased soil toxicity. Environ Sci Technol Lett. 6(11):675–680. doi: 10.1021/acs.estlett.9b00600.
   Web of Science ®Google Scholar
• Tao F, Ma S, Tao H, Jin L, Luo Y, Zheng J, Xiang W, Deng H. 2021. Chitosan-based drug delivery systems: from synthesis strategy to osteomyelitis treatment – A review. Carbohydr Polym. 251:117063. doi: 10.1016/j.carbpol.2020.117063.
   PubMed Web of Science ®Google Scholar
• Tawre MS, Shiledar A, Satpute SK, Ahire K, Ghosh S, Pardesi K. 2022. Synergistic and antibiofilm potential of Curcuma aromatica derived silver nanoparticles in combination with antibiotics against multidrug-resistant pathogens. Front Chem. 10:1029056. doi: 10.3389/fchem.2022.1029056.
   PubMed Web of Science ®Google Scholar
• Tenero D, Farinola N, Berkowitz EM, Tiffany CA, Qian Y, Xue Z, Raychaudhuri A, Gardiner DF. 2019. Pharmacokinetics, safety, and tolerability evaluation of single and multiple doses of GSK3342830 in healthy volunteers. Clin Pharmacol Drug Dev. 8(6):754–764. doi: 10.1002/cpdd.637.
   PubMed Web of Science ®Google Scholar
• Terrone D, Sang SLW, Roudaia L, Silvius JR. 2003. Penetratin and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential. Biochemistry. 42(47):13787–13799. doi: 10.1021/bi035293y.
   PubMed Web of Science ®Google Scholar
• Tiburcio E, García-Junceda E, Garrido L, Fernández-Mayoralas A, Revuelta J, Bastida A. 2021. Preparation and characterization of aminoglycoside-loaded chitosan/tripolyphosphate/alginate microspheres against E. coli. Polymers (Basel). 13(19):3326. doi: 10.3390/polym13193326.
   PubMed Web of Science ®Google Scholar
• Tong Z, Zhang Y, Ling J, Ma J, Huang L, Zhang L. 2014. An in vitro study on the effects of nisin on the antibacterial activities of 18 antibiotics against Enterococcus faecalis. PLoS One. 9(2):e89209. doi: 10.1371/journal.pone.0089209.
   PubMed Web of Science ®Google Scholar
• Tsukiura H, Koshiyama H, Knazima H, Organism D. 1964. Danomycin, a new antibiotic. J Antibiot Ser A. 17(2):39–47.
   PubMed Web of Science ®Google Scholar
• Tvilum A, Johansen MI, Glud LN, Ivarsen DM, Khamas AB, Carmali S, Mhatre SS, Søgaard AB, Faddy E, de Vor L. 2023. Antibody-drug conjugates to treat bacterial biofilms via targeting and extracellular drug release. Adv Sci. 10(23):e2301340. doi: 10.1002/advs.202301340
   Web of Science ®Google Scholar
• Valentin E, Bottomley AL, Chilambi GS, Harry EJ, Amal R, Sotiriou GA, Rice SA, Gunawan C. 2020. Heritable nanosilver resistance in priority pathogen: a unique genetic adaptation and comparison with ionic silver and antibiotics. Nanoscale. 12(4):2384–2392. doi: 10.1039/c9nr08424j.
   PubMed Web of Science ®Google Scholar
• van Houten NE, Zwick MB, Menendez A, Scott JK. 2006. Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide. Vaccine. 24(19):4188–4200. doi: 10.1016/j.vaccine.2006.01.001.
   PubMed Web of Science ®Google Scholar
• Vasilchenko AS, Vasilchenko AV, Pashkova TM, Smirnova MP, Kolodkin NI, Manukhov IV, Zavilgelsky GB, Sizova EA, Kartashova OL, Simbirtsev AS, et al. 2017. Antimicrobial activity of the indolicidin-derived novel synthetic peptide In-58. J Pept Sci. 23(12):855–863. doi: 10.1002/psc.3049.
   PubMed Web of Science ®Google Scholar
• Vassiliadis G, Destoumieux-Garzón D, Lombard C, Rebuffat S, Peduzzi J. 2010. Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47. Antimicrob Agents Chemother. 54(1):288–297. doi: 10.1128/AAC.00744-09.
   PubMed Web of Science ®Google Scholar
• Wali N, Shabbir A, Wajid N, Abbas N, Naqvi SZH. 2022. Synergistic efficacy of colistin and silver nanoparticles impregnated human amniotic membrane in a burn wound infected rat model. Sci Rep. 12(1):6414. doi: 10.1038/s41598-022-10314-9.
   PubMed Web of Science ®Google Scholar
• Wang Z, Tang M. 2021. Research progress on toxicity, function, and mechanism of metal oxide nanoparticles on vascular endothelial cells. J Appl Toxicol. 41(5):683–700. doi: 10.1002/jat.4121.
   PubMed Web of Science ®Google Scholar
• Wang DY, van der Mei HC, Ren Y, Busscher HJ, Shi L. 2019. Lipid-based antimicrobial delivery-systems for the treatment of bacterial infections. Front Chem. 7:872. doi: 10.3389/fchem.2019.00872.
   PubMed Web of Science ®Google Scholar
• Wang YY, Zhang XY, Zhong XL, Huang YJ, Lin J, Chen WM. 2023. Design and synthesis of 3-hydroxy-pyridin-4(1H)-ones-ciprofloxacin conjugates as dual antibacterial and antibiofilm agents against Pseudomonas aeruginosa. J Med Chem. 66(3):2169–2193. doi: 10.1021/acs.jmedchem.2c02044.
   PubMed Web of Science ®Google Scholar
• Waters V, Ratjen F. 2014. Inhaled liposomal amikacin. Expert Rev Respir Med. 8(4):401–409. doi: 10.1586/17476348.2014.918507.
   PubMed Web of Science ®Google Scholar
• Weaver E, Macartney RA, Irwin R, Uddin S, Hooker A, Burke GA, Wylie MP, Lamprou DA. 2024. Liposomal encapsulation of amoxicillin via microfluidics with subsequent investigation of the significance of PEGylated therapeutics. Int J Pharm. 650:123710. doi: 10.1016/j.ijpharm.2023.123710.
   PubMedGoogle Scholar
• Weber MM, Faris R. 2018. Subversion of the endocytic and secretory pathways by bacterial effector proteins. Front Cell Dev Biol. 6:1. doi: 10.3389/fcell.2018.00001.
   PubMed Web of Science ®Google Scholar
• Wencewicz TA, Miller MJ. 2017. Sideromycins as pathogen-targeted antibiotics. Top Med Chem. 26:151–184. doi: 10.1007/7355_201.
   Google Scholar
• Wencewicz TA, Long TE, Möllmann U, Miller MJ. 2013. Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target staphylococcus aureus. Bioconjug Chem. 24(3):473–486. doi: 10.1021/bc300610f.
   PubMed Web of Science ®Google Scholar
• Wencewicz TA, Miller MJ. 2013. Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii. J Med Chem. 56(10):4044–4052. doi: 10.1021/jm400265k.
   PubMed Web of Science ®Google Scholar
• Wencewicz TA, Möllmann U, Long TE, Miller MJ. 2009. Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin “trojan Horse” antibiotics and synthetic desferridanoxamine- antibiotic conjugates. Biometals. 22(4):633–648. doi: 10.1007/s10534-009-9218-3.
   PubMed Web of Science ®Google Scholar
• WHO. 2017. WHO publishes list ofbacteria for which newantibiotics are urgently needed.
   Google Scholar
• Wieczorek M, Jenssen H, Kindrachuk J, Scott WRP, Elliott M, Hilpert K, Cheng JTJ, Hancock REW, Straus SK. 2010. Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem Biol. 17(9):970–980. doi: 10.1016/j.chembiol.2010.07.007.
   PubMedGoogle Scholar
• Wiguna OD, Waturangi DE, Yogiara. 2022. Bacteriophage DW-EC with the capability to destruct and inhibit biofilm formed by several pathogenic bacteria. Sci Rep. 12(1):18539. doi: 10.1038/s41598-022-22042-1.
   PubMed Web of Science ®Google Scholar
• Wilson B. R., Bogdan AR, Miyazawa M, Hashimoto K, Tsuji Y. 2016. Siderophores in Iron Metabolism: from Mechanism to Therapy Potential. Trends Mol Med. 22(12):1077–1090. doi: 10.1016/j.molmed.2016.10.005.
   PubMed Web of Science ®Google Scholar
• Winkelmann G. 1990. Structural and stereochemical aspects of iron transport in fungi. Biotechnol Adv. 8(1):207–231. doi: 10.1016/0734-9750(90)90013-2.
   PubMed Web of Science ®Google Scholar
• Woodford N, Ellington MJ. 2007. The emergence of antibiotic resistance by mutation. Clin Microbiol Infect. 13(1):5–18. doi: 10.1111/j.1469-0691.2006.01492.x.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2019. WHO report on surveillance of antibiotic consumption.
   Google Scholar
• Worthington RJ, Melander C. 2013. Combination approaches to combat multi-drug resistant bacteria the problem of multi drug-resistant bacteria. Trends Biotechnol. 31(3):177–184. doi: 10.1016/j.tibtech.2012.12.006.
   PubMed Web of Science ®Google Scholar
• Wroe JA, Johnson CT, García AJ. 2020. Bacteriophage delivering hydrogels reduce biofilm formation in vitro and infection in vivo. J Biomed Mater Res A. 108(1):39–49. doi: 10.1002/jbm.a.36790.
   PubMed Web of Science ®Google Scholar
• Wu Y, Song Z, Wang H, Han H. 2019. Endogenous stimulus-powered antibiotic release from nanoreactors for a combination therapy of bacterial infections. Nat Commun. 10(1):4464. doi: 10.1038/s41467-019-12233-2.
   PubMedGoogle Scholar
• Xie J, Bi Y, Zhang H, Dong S, Teng L, Lee RJ, Yang Z. 2020. Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application. Front Pharmacol. 11:697. doi: 10.3389/fphar.2020.00697.
   PubMed Web of Science ®Google Scholar
• Xiong MH, Bao Y, Yang XZ, Zhu YH, Wang J. 2014. Delivery of antibiotics with polymeric particles. Adv Drug Deliv Rev. 78:63–76. doi: 10.1016/j.addr.2014.02.002.
   PubMed Web of Science ®Google Scholar
• Xu J, Li Y, Wang H, Zhu M, Feng W, Liang G. 2021. Enhanced antibacterial and anti-biofilm activities of antimicrobial peptides modified silver nanoparticles. Int J Nanomedicine. 16:4831–4846. doi: 10.2147/IJN.S315839.
   PubMed Web of Science ®Google Scholar
• Xu J, Xiang Y. 2017. Membrane penetration by bacterial viruses. J Virol. 91(13):e00162-17. doi: 10.1128/JVI.00162-17.
   PubMed Web of Science ®Google Scholar
• Yacoby I, Bar H, Benhar I. 2007. Targeted drug-carrying bacteriophages as antibacterial nanomedicines. Antimicrob Agents Chemother. 51(6):2156–2163. doi: 10.1128/AAC.00163-07.
   PubMed Web of Science ®Google Scholar
• Yacoby I, Shamis M, Bar H, Shabat D, Benhar I. 2006. Targeting antibacterial agents by using drug-carrying filamentous bacteriophages. Antimicrob Agents Chemother. 50(6):2087–2097. doi: 10.1128/AAC.00169-06.
   PubMed Web of Science ®Google Scholar
• Yan J, Mao J, Xie J. 2014. Bacteriophage polysaccharide depolymerases and biomedical applications. BioDrugs. 28(3):265–274. doi: 10.1007/s40259-013-0081-y.
   PubMed Web of Science ®Google Scholar
• Yang W, Wang L, Mettenbrink EM, Deangelis PL, Wilhelm S. 2021. Nanoparticle Toxicology. Annu Rev Pharmacol Toxicol. 61(1):269–289. doi: 10.1146/annurev-pharmtox-032320-110338.
   PubMed Web of Science ®Google Scholar
• Yeh YC, Huang TH, Yang SC, Chen CC, Fang JY. 2020. Nano-based drug delivery or targeting to eradicate bacteria for infection mitigation: a review of recent advances. Front Chem. 8:286. doi: 10.3389/fchem.2020.00286.
   PubMed Web of Science ®Google Scholar
• Yousef MI, Abuzreda AA, Kamel MAEN. 2019. Neurotoxicity and inflammation induced by individual and combined exposure to iron oxide nanoparticles and silver nanoparticles. J Taibah Univ Sci. 13(1):570–578. doi: 10.1080/16583655.2019.1602351.
   Web of Science ®Google Scholar
• Yu R, Wang J, So L-Y, Harvey PJ, Shi J, Liang J, Dou Q, Li X, Yan X, Huang Y-H, et al. 2020. Enhanced activity against multidrug-resistant bacteria through coapplication of an analogue of tachyplesin i and an inhibitor of the QseC/B signaling pathway. J Med Chem. 63(7):3475–3484. doi: 10.1021/acs.jmedchem.9b01563.
   PubMed Web of Science ®Google Scholar
• Zahid M, Robbins PD. 2015. Cell-type specific penetrating peptides: therapeutic promises and challenges. Molecules. 20(7):13055–13070. doi: 10.3390/molecules200713055.
   PubMed Web of Science ®Google Scholar
• Zaid Alkilani A, Hamed R, Musleh B, Sharaire Z. 2024. Breaking boundaries: the advancements in transdermal delivery of antibiotics. Drug Deliv. 31(1):2304251. doi: 10.1080/10717544.2024.2304251
   PubMed Web of Science ®Google Scholar
• Zasloff M. 1987. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A. 84(15):5449–5453. doi: 10.1073/pnas.84.15.5449.
   PubMed Web of Science ®Google Scholar
• Zeiders SM, Chmielewski J. 2021. Antibiotic–cell-penetrating peptide conjugates targeting challenging drug-resistant and intracellular pathogenic bacteria. Chem Biol Drug Des. 98(5):762–778. doi: 10.1111/cbdd.13930.
   PubMed Web of Science ®Google Scholar
• Zeng P, Yi L, Xu J, Gao W, Xu C, Chen S, Chan KF, Wong KY. 2021. Investigation of antibiofilm activity, antibacterial activity, and mechanistic studies of an amphiphilic peptide against Acinetobacter baumannii. Biochim Biophys Acta Biomembr. 1863(6):183600. doi: 10.1016/j.bbamem.2021.183600.
   PubMed Web of Science ®Google Scholar
• Zhang J, Leifer C, Rose S, Chun DY, Thaisz J, Herr T, Nashed M, Joseph J, Perkins WR, DiPetrillo K. 2018. Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages. Front Microbiol. 9:915. doi: 10.3389/fmicb.2018.00915.
   PubMed Web of Science ®Google Scholar
• Zhang P, Lock LL, Cheetham AG, Cui H. 2014. Enhanced cellular entry and efficacy of tat conjugates by rational design of the auxiliary segment. Mol Pharm. 11(3):964–973. doi: 10.1021/mp400619v.
   PubMedGoogle Scholar
• Zhang W, Mehta A, Tong Z, Esser L, Voelcker NH. 2021. Development of polymeric nanoparticles for blood–brain barrier transfer—strategies and challenges. Adv Sci. 8(10):2003937. doi: 10.1002/advs.202003937
   Web of Science ®Google Scholar
• Zhang QY, Yan Z, Bin Meng YM, Hong XY, Shao G, Ma JJ, Cheng XR, Liu J, Kang J, Fu CY, et al. 2021. Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res. 8(1):48. doi: 10.1186/s40779-021-00343-2
   PubMed Web of Science ®Google Scholar
• Zheng T, Nolan EM. 2015. Evaluation of (acyloxy)alkyl ester linkers for antibiotic release from siderophore-antibiotic conjugates. Bioorg Med Chem Lett. 25(21):4987–4991. doi: 10.1016/j.bmcl.2015.02.034.
   PubMed Web of Science ®Google Scholar
• Zorko M, Langel Ü. 2005. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev. 57(4):529–545. doi: 10.1016/j.addr.2004.10.010.
   PubMed Web of Science ®Google Scholar
• Zurabov F, Glazunov E, Kochetova T, Uskevich V, Popova V. 2023. Bacteriophages with depolymerase activity in the control of antibiotic resistant Klebsiella pneumoniae biofilms. Sci Rep. 13(1):15188. doi: 10.1038/s41598-023-42505-3.
   PubMed Web of Science ®Google Scholar